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1.  Abstract 
One of the hallmarks of cancer is the loss of telomere stability. Unprotected telomeres are 
prone to aberrant end-joining reactions that lead to chromosomal fusions and 
translocations. Human telomeres are formed by the repeated TTAGGG sequence, in 
which the 3’ exposed strand may adopt a G-quadruplex (G4) structure. The guanine-rich 
regions of telomeres are hotspots for oxidation forming 8-oxoguanine, a lesion that is 
handled by the base excision repair (BER) pathway. One key player of this pathway is 
Ape1, the main human endonuclease processing abasic sites. Recent evidences showed 
an important role for Ape1 in telomeric physiology, but the molecular details regulating 
Ape1 enzymatic activities on G4 telomeric sequences are lacking. Through a combination 
of in vitro assays, we demonstrate that Ape1 can bind and process different G4 structures 
containing an abasic site analog (THF) in two different locations and that the interaction 
involves specific acetylatable lysine residues (i.e. K27/K31/K32/K35) present in the 
unstructured N-terminal domain of the protein. The cleavage of the abasic site located in 
a G4 structure by Ape1 depends on the DNA conformation or the position of the lesion 
and on electrostatic interactions between the protein and the nucleic acids. Moreover, 
Ape1 mutants mimicking the acetylated protein display increased cleavage activity for 
abasic sites. We found that nucleophosmin (NPM1), which binds the N-terminal domain 
of Ape1, plays a role in modulating telomere length and Ape1 activity at abasic G4 
structures. Thus, the Ape1 N-domain is an important relay site for regulating the enzyme’s 
activity on G4-telomeric sequences, and specific acetylatable lysine residues constitute 




2.  Abbreviations 
 
ALT  Alternative Lengthening of Telomeres 
AP  Apurinic/apyrimidinic site 
Ape1  AP endonuclease 1 
BER  Base Excision Repair  
F   Tetrahydrofuran 
G4  G-quadruplex 
OG  8-oxo-7,8-dihydroGuanine 
Lys  Lysine 
nCaRE  negative Calcium Responsive Element 
NPM1  Nucleophosmin 1 
PTM  Post-Translational Modification 
ROS  Reactive Oxygen Species 
TERC  Telomere RNA Component 
TERT  Telomere Reverse Transcriptase 
TERRA Telomeric Repeat-containing RNA 
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4.  Introduction 
 
4.1. Cancer cells features 
Cancer cells are characterized by several hallmarks, which distinguish them from healthy 
cells. Tumor cells are able to avoid immune recognition, to favor tumor-promoting 
inflammation, to escape apoptosis and sustain proliferative signaling and also to 
overcome genomic instability (Hanahan and Weinberg 2011). Characterized by point 
mutations and chromosomal rearrangements, genome instability is one of the key 
elements that lead to cancer development through oncogene activation, or inactivation of 
tumor-suppressor genes (Figure 1) (Grandér 1998). Also, the majority of tumors are 
characterized by loss of checkpoint functions, compromised DNA repair activities and 
immortalization to reach a limitless replication (Ciccia and Elledge 2010; Hanahan and 
Weinberg 2011). 
Furthermore, to achieve immortalization and to maintain telomere length, the activity of 
telomerase enzyme is fundamental (Olovnikov 1996). When damaged, telomeres can 
participate in aberrant end-joining reactions leading to chromosome fusions, 
Figure 1 The hallmarks of cancer 
The illustration lists the main hallmark capabilities of tumor cells, whose underlying 
mechanisms are still widely investigated. (Hanahan and Weinberg, 2011). 
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translocations or breakage (Bailey 2006). Eukaryotic cells are continuously exposed, 
during their life-span, to several environmental stimuli (i.e. tobacco, UV light, smog, 
infections), both endogenous and exogenous, which represent damaging agents because 
they can impair macromolecules (Hoeijmakers 2001). DNA retains an intrinsic reactivity 
which gets the molecule a susceptible target for damages from various sources. To avoid 
harmful consequences that could lead to lethal outcomes for the cells, they adopt several 
mechanisms to ensure DNA integrity (Figure 2). Unrepaired DNA damages could result 
in cell death, limitless proliferation and cancer (Wilson and Bohr 2007).  
 
To counteract these outcomes, several mechanisms are employed by the cells to maintain 
genome stability, including DNA repair, cell cycle checkpoints and apoptosis pathways 
(Bauer, Corbett, and Doetsch 2015). DNA damage response pathways include several 
systems to repair specific DNA lesions. DDR mechanisms include the base excision 
repair, the nucleotide excision repair, the mismatch repair, the homologous recombination 
and the non-homologous end joining pathways (Blanpain et al. 2011) (Figure 2). All these 
Figure 2 Overview of different damaging agents, DNA effects and relative DNA repair 
pathways 
The figure recapitulates for each DNA damaging agent, the lesion induced on DNA and finally 
DNA repair pathways acting on the lesions (Blanpain et al. 2011). 
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pathways are finely tuned and coordinated thanks to a crosstalk that ensures the proper 
repair of the occurring lesion. 
Most of the endogenous burden, associated with oxidative stress, is handled by the Base 
Excision DNA Repair (BER) pathway (Demple and Sung 2005; P. Liu and Demple 
2010). 
4.2. Base Excision Repair (BER) pathway  
Base excision repair pathway is one of the most important pathways involved in the repair 
of DNA lesions and in the maintenance of genomic integrity, and it is essential to ensure 
viability of mammalian cells (Markkanen 2017). In fact, if key players of BER pathway 
are not expressed, this leads to embryonic lethality (Iyama and Wilson 2013). 
BER is involved in the removal of damaged bases, for example, by oxidation, alkylation 
or deamination. Several enzymes are recruited to complete the process (Figure 3), which 
is composed of five essential steps (Akbari et al. 2015).  
Figure 3 Graphical representation of the main BER steps 
After the cleavage of the N-glycosyl bond by specific DNA glycosylases, AP endonuclease (Ape1) 
cuts the phosphodiester bond. The resulting gap is then filled by DNA polymerases and ligases 
(Akbari et al. 2015). 
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As a first step, this pathway identifies the abnormality in the DNA sequence through the 
intervention of a glycosylase, which specifically recognize the modified base. This is 
flipped out and cleaved, giving rise to an abasic site through the hydrolysis of the N-
glycosyl bond (Wallace 2013). The abasic site is then processed by Ape1 
(Apurinic/apyrimidinic endonuclease 1, Bauer, Corbett, and Doetsch 2015) that cuts the 
phosphodiester backbone 5’ to the AP site generating a 3’ OH and 5’-deoxyribose-5-
phosphate (Demple and Sung 2005). The nick is then handled by Pol β that replaces only 
the nucleotide containing the removed base (Howard and Wilson 2017), or alternatively 
by Pol δ/ε, which replace 2-12 nucleotides. In dependence of the involvement of the 
different polymerases, the pathway is called short patch or long patch respectively. In the 
short patch BER, ligase III is involved to seal the nick left after Pol β action (Sobol et al. 
1996). In the long patch after Pol δ/ε intervention, FEN-1, PCNA and ligase I are recruited 
to remove the excess flap bases and complete the repair process (Sung, DeMott, and 
Demple 2005). 
  
4.3. Apurinic/apyrimidinic endonuclease 1 (Ape1) 
Ape1 is the major AP endonuclease in mammals (Hadi et al. 2002). Besides its role in 
BER pathway, it was recently discovered that Ape1 has several other activities (Antoniali 
et al. 2017). Ape1 presence is important for the DNA repair process, so it is considered a 
key player in BER (Tell et al. 2009). Ape1 is an abundant protein, with a density of ~104 
- 105 copies/cell, and with a relatively long half-life of almost 8 hours (Tell et al. 2009; 
Vascotto et al. 2009). The APE1 gene is located on chromosome 14q11.2-q12 and it is 
2.6 kbp long, composed of five exons and four introns (Robson et al. 1992). Multiple 
transcription start sites (TSSs) are present on the gene, to control both the constitutive and 
the inducible expression of the protein. In the proximal promoter region the consensus 
sequence for Sp1 transcription factor is located, which binds the promoter (Zaky et al. 
2008). Sp1 is responsible for both constitutive transcription and for the increase during 
S-phase of the cell-cycle (Rivkees and Kelley 1994; Zaky et al. 2008). 
Ape1 is a 35.55 kDa protein, composed of 318 amino acids. It is a monomeric protein 
with a globular structure containing α/β sandwiches and an unstructured N-terminal 
domain of 48 amino acids (Gorman et al. 1997). 
Three functional domains of Ape1 can be defined: 
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• The N-terminal domain (aa 1-35) involved in protein-protein interaction and in 
interactions with nucleic acids (Poletto et al. 2013),  
• The intermediate domain (aa 35-127), dedicated to transcription factors regulation 
through redox activity (Fantini et al. 2010; Lirussi et al., 2012), 
• The C-terminal domain (aa 127-318) which conducts endonuclease activity (Tell 
et al. 2009). 
Ape1 is subjected to several post-translational modifications, especially at its first 35 
residues (Figure 4).  
A very well described in vivo post-translational modification is the truncation of the 
protein occurring at its first 33 amino acids (Bhakat et al. 2016; Timofeyeva et al. 2009). 
The cleavage reaction is carried on by a still not identified granzyme-like enzyme 
(Yoshida et al. 2003). The deletion mutant lacks the nucleolar localization signal located 
in the N-terminus domain, so this protein displays a cytoplasmic localization (Jackson et 
al. 2005), and its ability to interact with canonical protein partners is hampered (Vascotto 
et al. 2009). Phosphorylation of the N-terminal domain inhibits Ape1 endonuclease 
activity while enhancing its redox activity (Busso, Lake, and Izumi 2010; Huang et al. 
2010). Acetylation involves lysine residues K6, K7, K27, K31, K32 and K35 with the effect 
of decreasing the interactions with other protein partners, such NPM1, inhibiting the 
accumulation of Ape1 in the nucleoli (Lirussi et al. 2012; Busso, Lake, and Izumi 2010). 
Figure 4 Structural organization of Ape1 protein 
Each domain of Ape1 has a specific function. N-terminus is engaged in nucleolar localization, 
protein-protein interaction and nucleic acid binding. Redox domain interacts with transcription 
factors to regulate their action and C-terminal domain is the responsible for the endonuclease 
activity of the protein. The listed amino acids are involved in the specified post-translational 
modifications or activity. 
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Moreover, acetylation also affects the affinity of Ape1 toward nucleic acids, due to the 
neutralization of the positive charges of residues K27, K31, K32 and K35. Furthermore, the 
neutralization of the N-terminal arm of Ape1 induces a conformational change that 
increases the endonuclease activity of the protein (Roychoudhury et al. 2016; Fantini et 
al. 2010). Moreover, acetylated Ape1 results in a more enzymatically active form, so the 
protein can process DNA lesions faster (Fantini et al. 2008; Lirussi et al. 2012; Fantini et 
al. 2010; Roychoudhury et al. 2016). 
The endonuclease activity incises in correspondence of the AP site, at its 5’ on the 
phosphodiester backbone. After the cleavage, the single strand break is flanked by the 3’-
hydroxyl (OH) and at the 5’-deoxyribose phosphate. Ape1 recognizes the abasic site, and 
subsequently excludes the dNTP, distorting the DNA backbone of about 35° (Figure 5). 
 
The active site is defined by several residues. Phe226 is implicated in AP site recognition, 
Asp210 and Asn212 play a critical role in hydrolyzing the phosphodiester bond and 
Tyr171 with His309 direct the proper disposition of the AP substrate (Freudenthal et al. 
2015; Mundle et al. 2009). Moreover, Asp283 and Asp308 are involved in maintaining 
the active site conformation (Evans, Limp-Foster, and Kelley 2000). The enzymatic 
reaction goes on upon a further rearrangement between Ape1 and DNA, which is 
Figure 5 Cartoon representation of the Ape1-DNA complex 
The protein is shown in yellow and the arrow indicates the cleavage. The abasic site is 
represented by the THF (Freudenthal et al., 2015). 
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dependent on the presence of Mg++ acting as enzymatic co-factor, positioned at the active 
site (Glu 96 and Asp70), to promote the spatial reorganization (Erzberger and Wilson 
1999; Tell, Wilson, and Lee 2010). A water molecule is also needed to carry on the 
cleavage reaction, which requires the presence of a nucleophile (Freudenthal et al. 2015; 
Manvilla et al. 2013). Quite recently, it has been demonstrated that Ape1 is also involved 
in RNA metabolism (Tell, Wilson, and Lee 2010; Antoniali et al. 2017). Furthermore, 
Arg177 and Met270 participate in DNA binding to maintain Ape1 locked on the substrate 
(Kaur et al. 2014).  
Another fundamental function of Ape1 consists in its ability of working as co-activator 
of transcription factors through a redox mechanism, which allows to regulate gene 
expression. The key residues are Cys65 and Cys93 (Walker et al. 1993) and Cys99 (Luo 
et al. 2012), through which Ape1 keeps reduced critical Cys residues of some 
transcription factors. In particular, the crucial residue is represented by the Cys65, 
considered as the nucleophilic residue in the reduction of disulphide bonds in TFs. All 
the three cysteines are buried in a hydrophobic pocket, so it has been suggested that a 
conformational change is required to allow the contribution of these residues (Luo et al. 
2012; Su et al. 2011). 
Ape1 is also involved in nucleotide incision repair (NIR) by incising in a DNA 
glycosylase-independent manner substrates carrying a 3’ OH (Gros et al. 2004). This 
pathway is activated to support BER pathway when glycosylases are absent or unable to 
process the lesion, usually resulting from oxidative stress (Timofeyeva et al. 2011). In the 
NIR context, Ape1 cuts at the 5’ of the oxidized base without the intervention of a 
glycosylase, producing a 3’ OH extremity that is then processed by FEN1. The repair is 
then completed by the action of polymerases (Ischenko and Saparbaev 2002). Ape1 NIR 
activity is exerted at pH values of 6.4- 6.8 and KCl concentration of 50 mM. NIR is highly 
exerted by Ape1 at 100-fold lower MgCl2 concentration, compared to AP-endonuclease 
activity (Gros et al. 2004). The N-terminal domain of the protein, fundamental for the 
protein-protein and protein-nucleic acid interaction, is not fundamental for the AP-
endonuclease activity but is indispensable for the NIR activity (Izumi et al. 2005). 
Ape1 is able to in vitro process single-stranded RNA containing abasic sites (Berquist, 
McNeill, and Wilson III 2008), to interact with ribosomal RNA to assist its processing 
(Vascotto et al. 2009), and to interact with several proteins implicated in RNA processing, 
i.e. NPM1. The interaction between Ape1 and NPM1 could compete with the contact of 
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each protein with RNA binding. The use of inhibitors of Ape1-NPM1 interactions in 
tumor cells, where both Ape1 and NPM1 are overexpressed and their interaction is 
functional for cancer cell proliferation, results in improvement of the contacts of each 
protein with rRNAs (Poletto et al. 2016). A recently published work highlights the action 
of Ape1 on abasic and oxidized ribonucleotides embedded in DNA (Malfatti et al. 2017). 
The protein can process ribonucleotide abasic sites incorporated in DNA with the same 
efficiency as deoxy-abasic sites (Malfatti et al. 2017). This evidence is interesting as it 
confirms the role of Ape1 in processing RNA substrates and it highlights the importance 
of the protein in the maintenance of genome integrity, as oxidative damage is a very 
common lesion involving ribonucleotides incorporated in DNA that is handled by BER. 
4.3.1. Ape1 as regulator of gene expression  
Besides its canonical role as fundamental enzyme in the BER pathway that is well 
characterized, Ape1 could be also considered a regulator of gene expression through 
different and yet not completely unveiled mechanisms. Indeed, Ape1 plays a role in the 
regulation of expression of human genes during oxidative stress conditions both through 
direct and indirect mechanisms, being therefore important for cancer biology (Tell, 
Wilson, and Lee 2010; Li and Wilson 2014; Antoniali et al. 2017).  
Ape1 direct role in transcriptional regulation 
Recent findings highlighted that epigenetic mechanisms seem to crosstalk with DNA 
damage. In detail, oxidative DNA lesions appear to act as epigenetic-like marks through 
the recruitment of the DNA repair machinery, thus modulating gene expression in cells 
exposed to oxidative stress (Fleming and Burrows 2017; Fleming, Ding, and Burrows 
2017; Perillo et al. 2008). Oxidation of the guanine is a frequent event leading to 8-oxo-
7,8-dihydroguanine (OG) formation, which is a highly mutagenic modification (Figure 
6). If RNA polymerases face an OG during transcription, this could cause the stalling of 
the enzyme, leading to the repression of transcription. It was recently demonstrated that 
if OG is present at the promoter level of some genes, the transcription can be increased 
via the BER pathway (Fleming and Burrows 2017; Fleming, Ding, and Burrows 2017). 
The glycosylase OGG1 removes the OG, generating an AP site that unmasks the G-
quadruplex structure and is bound but not efficiently cleaved by Ape1 (Fleming, Ding, 
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and Burrows 2017). So Ape1 may, in coordination with other BER partners, bridge other 
transcription factor regulators, intertwining DNA repair with transcription activation. 
 
It was observed that Ape1 is able to regulate transcription through the binding via its N-
terminal domain to bind specific DNA regulatory sequences, known as nCaRE, which are 
widely present among the genome (Antoniali, Lirussi, D’Ambrosio, et al. 2014, 1). These 
elements are found in the context of promoters of many genes. They are present also in 
the promoter of Ape1 gene, and Ape1 protein can bind it thanks to the involvement of a 
protein complex, including also hnRNPL, Ku70/80 and PARP-1, participating in a 
negative regulation of its own gene (Izumi, Henner, and Mitra 1996; Antoniali, Lirussi, 
D’Ambrosio, et al. 2014). On the contrary, when Ape1 binds the nCaRE sequences 
present on the SIRT1 promoter, this stimulates the transcription in case of oxidative 
stress. That is because, upon the AP endonuclease activity of Ape1, the promoter gains 
in flexibility and consequently the chromatin is locally relaxed, thus easing there the 
assembly of the transcription complex (Pastukh et al. 2015; Antoniali, Lirussi, 
D’Ambrosio, et al. 2014). 
Ape1 indirect role in transcriptional regulation 
Redox regulation is achieved through the modulation of TFs activity, especially targeting 
specific cysteine (Cys) residues located in their DNA-binding domains or regulatory sites, 
as pointed out by several studies (Evans, Limp-Foster, and Kelley 2000; Tell et al. 2005). 
Actually, these critical cysteines need to be in their reduced state to allow TFs proper 
binding to the target DNA sequences (Tell et al. 2005). So far, Ape1 is the only known 
DNA repair protein that also possesses nuclear transcriptional regulatory activity in 
mammals (Georgiadis et al. 2008). Through its intervention, Ape1 maintains several TFs 
Figure 6 Representation of the product of guanine oxidation 
8-oxo-7,8-dihydroguanine is one of the most common oxidative DNA lesions, formed under 
various oxidative conditions. 
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in their reduced and active state, influencing gene expression and maintaining genomic 
stability within the cells (Kelley, Georgiadis, and Fishel 2012). Ape1 modulates the redox 
status of both ubiquitous and tissue-specific transcription factors, such as AP-1, Egr-1, 
NF-κB and p53 (Tell et al. 2005; Li and Wilson 2014; Kelley, Georgiadis, and Fishel 
2012). These and others TFs are involved in the regulation of many different cellular 
mechanisms, ranging from cell proliferation and growth to apoptosis, included cancer 
promotion (Kelley, Georgiadis, and Fishel 2012; Kaur et al. 2014; Fantini et al. 2008). 
Ape1 role as a redox factor is exerted by its N-terminal domain, through a mechanism not 
yet fully understood. It was described that, after a partial structural rearrangement of the 
protein, Cys65 acts as the nucleophile residue for the reduction of the disulphide bond 
between two cysteines on the oxidized target TF, which is then reduced (Luo et al. 2012). 
Meanwhile, Cys65 establishes a new disulphide bond with Cys93 or 99 upon Ape1 
oxidation process. In this way, Ape1 protein may contribute to preserve the cell from the 
genotoxic insults due to increased ROS concentration and unbalanced redox regulation. 
Recent findings highlighted a novel role for Ape1 in RNA biology. As RNA is a single-
stranded molecule, it is much more susceptible to oxidation compared to DNA. RNA 
damage is as a frequently observed feature in several human cancer types (Simms and 
Zaher 2016). Thus, RNA quality control mechanisms are crucial to avoid catastrophic 
effects such as ribosomal impairment, error-prone translation and, consequently, failed 
protein synthesis and altered gene expression (Vohhodina, Harkin, and Savage 2016). 
Ape1 was recently identified as a directly involved player in RNA control process, as 
through its N-terminal domain it interacts with RNA molecules and with other protein 
partners participating in RNA processing (Vascotto et al. 2009; Poletto et al. 2013). In 
particular, Ape1 interacts with the nucleolar ribosome biogenesis-related protein 
nucleophosmin 1 (NPM1) and with rRNA molecules in nucleoli. Moreover, Ape1 can 
process also RNA molecules, exerting an RNase H-like endoribonuclease activity 
(Berquist, McNeill, and Wilson III 2008; Tell, Wilson, and Lee 2010; Malfatti et al. 
2017). Under oxidative stress conditions Ape1-NPM1 interaction is interrupted and Ape1 
moves to nucleoplasm to exert its endonuclease function (Vascotto et al. 2009; Antoniali, 
Lirussi, Poletto, et al. 2014; Vohhodina, Harkin, and Savage 2016). Also acetylation of 
the lysine residues located in the N-terminus of the protein modulates Ape1 interaction 
with NPM1 and its cellular localization, suggesting that also PTMs play a role in 
regulating Ape1 functions (Lirussi et al. 2012). In this scenario, Ape1 serves as a 
scavenger of oxidatively damaged RNA molecules in order to maintain a functional 
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RNome (Tell, Wilson, and Lee 2010). Next, Ape1 can cleave c-myc RNA, controlling its 
half-life and tuning its turnover. These evidences support a role of Ape1 in RNA decay 
and quality control. 
It was recently demonstrated that Ape1 is able to bind miRNA molecules too, so the 
protein is involved in gene expression regulation also through this mechanism (Kim, 
King, and Lee 2010; Antoniali et al. 2017). Micro RNAs are short non-coding RNA 
molecules able to regulate a variety of pathways, controlling the translation of RNA 
transcripts. These molecules are translated by RNA pol II and the product is called pri-
miRNA because this primary transcript needs to be then modified to obtain a hairpin 
structure named pre-miRNA. Pre-miRNAs are exported in the cytoplasm and there 
processed to obtain the mature double-stranded RNA sequence that is 22 nucleotides 
long. Only one filament of the duplex constitutes the active effector on the target RNA, 
which is involved in transcription repression by pairing with the complementary RNA. 
Ape1 seems to be also involved in miRNA maturation as, when silenced, a different 
miRNA expression profile was detected (Antoniali et al. 2017). Upon depletion of Ape1, 
the oxidation of miRNAs increased, and an accumulation of pri-miRNAs was observed, 
coupled with a decrease of mature miRNAs. Probably Ape1 is involved in editing the 
precursors, consequently exerting a post-transcriptional key role in gene expression 
(Antoniali et al. 2017).  
Furthermore, other evidences pointed out how Ape1 may be involved in epigenetic 
regulation (Fleming, Ding, and Burrows 2017; Chen et al. 2017). 
Ape1 interactome 
Ape1 takes active part in a plethora of pathways, thus when its functionality is 
compromised, the repercussions could be wide and severe (Tell, Wilson, and Lee 2010). 
The functions and interactions of Ape1 are modulated by PTMs, which control also the 
subcellular localization of the protein. Recently, a number of interactor proteins were 
identified, who belong to five major areas (Figure 7) (Antoniali et al. 2017).  
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The recognized pathways are grouped in the regulation of transcription, apoptosis, DNA 
repair, double strand break repair and RNA processing fields. Of course, the DNA repair 
interactors mainly belong to the BER pathway, as Ape1 works as a coordinator of 
downstream enzymes (Limpose, Corbett, and Doetsch 2017). Within the RNA processing 
area, are listed proteins involved in RNA metabolism and also RNA molecules, both 
coding and non-coding, as Ape1 is also able to interact with these cellular components 
(Antoniali et al. 2017). Among the transcription regulation, several transcription factors 
Figure 7 Ape1 protein network 
Top five biological pathways to which Ape1 interactors are related: repair of DNA, apoptosis, 




are listed, which are regulated by Ape1 through its redox function. Finally, apoptosis-
regulating components include a lot of enzymes implicated in carrying post-translational 
modifications that act as signals influencing Ape1 interactions and localization (Fantini 
et al. 2010; Poletto et al. 2013; Lirussi et al. 2012).  
Ape1 in cancer 
Dysregulation of Ape1 is found in several human pathologies, including 
neurodegenerative disorders, cardiovascular diseases and carcinogenesis (Thakur et al. 
2015). Overexpression of Ape1 is observed in a few cancer types, in which an altered 
intracellular distribution is also observed (Tell et al. 2009, 2005). In particular, 
cytoplasmic localization is correlated with poor prognosis and more aggressive tumours, 
as observed in lung, ovarian, thyroid, breast cancer and hepatocellular carcinoma (Tell et 
al. 2009). These features may be responsible for further cell resistance toward 
chemotherapy since it may reflect an adaptive response to chronic oxidative stress 
(Wilson and Simeonov 2010; Poletto et al. 2016; Rai et al. 2012), which is the main cause 
of hepatic carcinogenesis and its progression, so enhancing both Ape1 DNA repair and 
redox activities (Di Maso et al. 2015). Moreover, Ape1 is implicated in chemoresistance 
thanks to its ability to induce the expression of the multi-drug resistance gene (MDR1), 
through its interaction with YB-1 (Sengupta et al. 2011), and thanks to its regulatory 
action against the expression of the tumor suppressor PTEN (Fantini et al. 2008). The 
protein could be considered as a potential target to sensitize the cells to chemotherapy, 
thus its altered expression levels could be employed as a predictive biomarker to evaluate 
the sensitivity of the tumour (Thakur et al. 2014, 1). As lysine residues (i.e. K27, K31, K32 
and K35) were found acetylated in cancer cells (Fantini et al. 2010; Poletto et al. 2012), 
this PTM might be employed as a mechanism to regulate the protein function. Base 
excision repair, and Ape1 action, are fundamental also at the telomeric level, as the 
disruption of the physiology of these regions play a role in tumor development, being 
involved in the raise of telomeric aberrations (Madlener et al. 2013). 
 
4.4. Telomeres organization 
Human telomeres extend for 10-15 kbp and are composed by the non-coding repeated 
sequence TTAGGG (Blasco 2003). Chromosome extremities end with a single-stranded 
overhang that is bound by the shelterin complex (de Lange 2005). This complex is 
composed by a group of proteins (Figure 8) that are required to maintain DNA integrity 
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and to mediate interactions with other protein partners (Oganesian and Karlseder 2009). 
The shelterin complex proteins are: TRF1, TRF2 (Telomeric repeat binding factor 1 and 
2), POT1 (Protection of telomeres 1), TIN2 (TRF-interacting protein), TPP1 (TIN2 and 
Figure 8 Representation of the chromosome ends protected by members of the shelterin 
complex 
(A) Linear (top) and folded T-loop (bottom) structural states of the telomere are depicted. (B) An 
anti-parallel intramolecular G-quadruplex either alone (top) or in the context of a T-loop 
(bottom) might cap the chromosome terminus to avoid their degradation or extension (Oganesian 
and Karlseder 2009). 
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POT-interacting protein) and RAP1 (Repressor/activator protein 1), whose presence is 
fundamental to ensure protection to telomeres (Liu et al. 2004). In particular, this complex 
also contributes to the folding of telomere into a structure called telomeric loop (T-loop), 
which guarantees the protection of the single-stranded filament, thanks to the pairing with 
the upstream complementary strand, creating a displacement loop (D-loop) (Doksani et 
al. 2013). The structure assumed by the protruding strand is functional to avoid the 
activation of the DNA damage machinery which would detect the unpaired filament as a 
site to be repaired (de Lange 2004). A feature of telomeres is the guanine-rich 
composition of the protruding strand, which is called G-overhang. The G-overhang is 
bound by a specific single-strand binding protein, POT1, Protection of telomeres 
(Baumann and Cech 2001). POT1 is essential in the formation of the T-loop, stabilizing 
the D-loop by binding the displaced filament (Oganesian and Karlseder 2009). The other 
proteins which establish a direct contact with the telomeres are TRF1 and TRF2, which 
specifically recognize the double-stranded tract of telomeric DNA. The presence of these 
two protein partners is essential: the homozygous deletion of either gene results in early 
embryonic lethality in mice (Celli and de Lange 2005). TRF2 contains a basic domain 
and a DNA-binding domain; if these two domains are deleted from TRF2 gene, that leads 
to the activation of DNA-damage response, marked by the presence of γH2AX, 53BP1, 
the loss of G-overhang and by end-to-end fusions (Agata Smogorzewska et al. 2002). 
Thus, TRF2 is involved in the inhibition of NHEJ pathway (Ribes-Zamora et al. 2013). 
Moreover, TRF2 is also involved in the suppression of illegitimate homologous 
recombination events at the telomeres. This is a fundamental role, as the D-loop resembles 
a Holliday junction recombination intermediate, so the HR pathway must be blocked in 
this context. The expression of a mutant TRF2 deprived of the basic domain results in 
loss of the T-loop, that leads to the formation of extrachromosomal telomeric circles, 
which provoked the activation of the DNA damage response and the induction of 
senescence (Wang, Smogorzewska, and de Lange 2004). It was demonstrated that TRF2 
also associates with the NER endonuclease complex XPF-ERCC1, which represses 
telomere recombination. This complex is also involved in promoting overhang removal, 
resulting in chromosome fusions in case of TRF2 deletion (Zhu et al. 2003). TRF1 and 
TRF2 are both involved in DNA remodeling. Through its homodimerization domain, 
TRF1 is able to loop, bend and induce synapsis of telomeric DNA (Griffith, Bianchi, and 
de Lange 1998). TRF2 can also induce strand invasions stimulating topological changes 
at the telomeres (Griffith et al. 1999; Verdun and Karlseder 2006). TRF2 is involved in 
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the stabilization of the T-loop invasion site by the overhang (Fouché et al. 2006). RAP1 
was demonstrated to be essential to protect telomeres from homology-directed repair of 
telomeres as it cooperates with the basic domain of TRF2 to repress PARP1 and SLX4 
localization to telomeres. Without RAP1 and TRF2B, PARP1 and SLX4 HR factors 
promote rapid telomere resection, resulting in telomere loss and in generation of 
chromosome fusions in human cells (Rai et al. 2016, 1).  
As DNA polymerase works only toward the 3’ direction, the leading strand is duplicated 
until the end, while the duplication of the lagging strand leaves out about 200 nucleotides 
at each cell cycle (d’Adda di Fagagna et al. 2003). Consequently, telomeres are 
progressively shortened by each cell replication (Harley, Futcher, and Greider 1990), until 
they reach a threshold length, which determines the exit from the cell cycle and the start 
of the senescence phase. The threshold at which the cell stops proliferating and enters in 
the senescent phase is called Hayflick limit (Hayflick and Moorhead 1961). Some cell 
types, such as germline cells, stem cells and cancer cells, are not subjected to telomere 
shortening because they activate some mechanisms to avoid senescence (Flores and 
Blasco 2010).  
4.4.1. G-quadruplex structures and their functions 
Telomeric sequences, which are guanine-rich, are characterized by the assumption of a 
G-quadruplex (G4) folding (Bugaut and Alberti 2015). The acquirement of this folding is 
supported by TRF2 protein (Pedroso, Hayward, and Fletcher 2009). G-quadruplex (G4) 
structures derive from the stacking of at least three planar tetrads which are established 
thanks to the formation of Hoogsten hydrogen bonds between the guanines interspersed 




They form in the presence of monovalent cations, such as Na+ or K+ which are coordinated 
between the stacked tetrads. Several quadruplex conformations exist: they are defined as 
parallel, antiparallel or hybrid in dependence of the direction in which the filament runs 
at each “corner” of the tetrad. The different conformation assumed depends on the type 
of cation, and on the length of the loops, which are the tracts interspersed between the 
guanine runs (Figure 10).  
 
Figure 10 Possible G-quadruplex structure conformations 
The representation shows the different G-quadruplex structures that can be assumed by a single 
stranded DNA sequence containing guanines. Guanine bases are represented by parallelepipeds 
and non-G residues located in the loops were omitted for clarity. Parallel (left), antiparallel 
(center) and hybrid (right) G4 are indicated and the arrows show the direction in which each 
strand runs. 
 
Figure 9 Representation of a planar tetrad 
The tetrad is established thanks to the hydrogen bonds, here dotted, between the hydroxyl and 




The parallel G4 is characterized by strands running all in the same direction, linked by 
double-chain reversal loops; the antiparallel G4 contains two strands running in one 
direction and the other two in the opposite and lateral or diagonal loops. The hybrid 
quadruplex is also called “3+1” as it results from three strands running in the same 
direction and one in the other; the loops are also mixed (Dai et al. 2007). Several G4 types 
can be formed in vitro and these structures are thermodynamically characterized by a 
higher stability than double-stranded DNA and DNA or RNA hairpins (Lane et al. 2008). 
The formation of G-quadruplex structures in vivo plays an important role in regulating 
DNA replication (Bochman, Paeschke, and Zakian 2012), indeed these secondary 
structures are unfolded by helicases (RecQ protein-like 4) which are cell-cycle dependent 
(Postberg et al. 2012). Rif1 also was demonstrated to participate in temporal and spatial 
regulation of DNA replication (Yamazaki, Hayano, and Masai 2013; Kanoh et al. 2015). 
Rif1 (Rap1 interacting factor) is a protein able to bind G4-structured binding sequences 
containing a consensus sequence (Masai et al. 2018). Rif1 preferentially binds to target 
sequences containing multiple G-tracts, suggesting that higher-order G4 structures allow 
a more efficient recognition by the protein. G4 structures are present at the promoter 
region of many genes (i.e. c-Myc, VEGF, SIRT1, TNFα), thus controlling the 
transcription through the unfolding of the region (Balasubramanian, Hurley, and Neidle 
2011).  
4.4.2. Telomere maintenance pathways  
Two telomere maintenance mechanisms are known: the telomerase-mediated telomere 




Telomerase is a special enzyme, which works as a reverse transcriptase (RT) from an 
RNA template. These two components are respectively called TERT and TERC (Feng et 
al. 1995; Harrington et al. 1997). The other key factor of the human telomerase complex, 
with TERT and TERC, is dyskerin that is involved in binding and stabilizing TERC 
(Cohen et al. 2007). While TERC and dyskerin are constitutively expressed, TERT 
constitutes the limiting factor in telomerase activity (Li et al. 2003). TERC is localized in 
Cajal bodies, small nuclear organelles implicated in RNA biogenesis and maturation. It 
was demonstrated that telomerase Cajal body protein1 (TCAB1) mediates the passage of 
Figure 11 Mechanisms of telomerase-driven (A) and HR-driven (B) synthesis of telomeric 
DNA 
(A.I) DNA synthesis is initiated with the alignment of the 3′ telomeric G-overhang (in blue) with 
the RNA template (in red). (A.II) Telomerase catalyzes nucleotide addition to the overhang until 
the 5′ end of the template is reached. (A.III) The enzyme translocates and realigns with the newly 
synthesized 3′ end of the overhang. (A.IV) A second round of nucleotide addition starts. (B) Both 
inter- and intratelomeric recombination events have been hypothesized to promote telomere 
maintenance in ALT. In both types of recombination, the 3′ overhang of the telomere initiates 
invasion and uses its host DNA as a template for DNA copying. (B.I) Intermolecular 
recombination might involve telomeres from two adjacent chromosomes or chromatids. (B.II) 
The telomere could also use itself as a template and synthesize DNA via rolling circle replication 
(Oganesian and Karlseder 2009). 
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telomerase RNA through Cajal bodies and assists the fully assembled complex in 
reaching the telomeres (Venteicher et al. 2009). The telomerase complex is highly 
expressed during embryonic development and its expression levels decrease after birth. 
In tumor cells the complex is often re-expressed to allow telomere elongation and ensure 
immortalization. TERT is, in somatic cells, under strict transcriptional control, while in 
cancer cells this regulation is lost. It was demonstrated that the expression of hTERT is 
influenced by epigenetic modifications on the promoter of the gene. Methylation of the 
promoter of hTERT heads to transcriptional inactivation, but it was stated that when CpG 
islands in the only proximal promoter region are methylated, this prevents the binding of 
transcriptional repressors such as CTCF (Renaud et al. 2007), thus leading to transcription 
activation. Also, acetylation of histone H3 and H4 activates the transcription of TERT 
gene, as it was demonstrated that after treatment with TSA, a histone deacetylase 
inhibitor, the methylation levels decrease, thus allowing CTCF binding and consequently 
suppressing TERT expression (Choi et al. 2010). TRF1 is involved in the negative 
regulation of telomerase-dependent maintenance of telomere length. This regulation is 
possible thanks to the crosstalk of TRF1 with POT1-TPP1 complex which controls the 
access of telomerase to the G-overhang. Telomere length is correlated to TRF1 
occupancy, as longer telomeres carry more TRF1 on them. The information is transmitted 
by TPP1 to POT1, which rends the G-overhang inaccessible to telomerase thanks to a 
stronger association with it (Loayza and De Lange 2003; Xin et al. 2007; Ye et al. 2004). 
This is supported by the fact that if TRF1 levels are altered through overexpression or 
downregulation, this results in telomere shortening or lengthening respectively (Loayza 
and De Lange 2003; Smogorzewska et al. 2000; Ancelin et al. 2002). The 85-90% of the 
tumors exploit telomerase re-expression to maintain telomere length, while the remaining 
10-15% of the cancer types use ALT. ALT pathway consists of homologous 
recombination, mainly post-replication, that can occur inter-molecularly using the 
telomere of the sister chromatid as template, or can be intramolecular, exploiting the T-
loop structure (De Vitis, Berardinelli, and Sgura 2018). As the ALT pathway is less 
strictly regulated, cells that exploit this system show heterogeneous telomere length. For 
example, if the alignment is asymmetric, this leads to unequal telomere elongation 
between the two chromatids. Asymmetric chromatid alignment could also give rise to 
uneven telomere-sister chromatid events (Oganesian and Karlseder 2009). The outcome 
would show a telomere-less chromosome and its sister with a proliferative advantage 
(Muntoni et al. 2009). In case of intramolecular recombination, T-loop junction resolution 
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can occur, generating truncated telomeres and T-circles that represent extra-chromosomal 
telomeric repeats (Cesare and Reddel 2008). In some cases, telomeres are not allowed to 
form T-loops due to their insufficient length. If so, TRF2 surveillance might be 
compromised. 
Telomeres were considered transcriptionally inactive, due to the high methylation levels 
of the subtelomeric regions and to the density of heterochromatic marks (trimethylation 
of histone H3 and H4 at lysine 9 and 20 respectively) at the telomeric level (Blasco 2007). 
Surprisingly, it was demonstrated that the transcription at the telomeric level occurs and 
it gives an RNA consisting of the repeated sequence UUAGGG, which was called 
TERRA (telomeric repeat-containing RNA) (Azzalin et al. 2007). This long non-coding 
RNA transcript derives from the activity of RNA polymerase II on the C-rich strand 
toward the chromosome end. TERRA molecules can range between 100 bp and 9 kb, but 
the most of them are approximately 200 bp long (Cusanelli and Chartrand 2015). The 
promoter is localized at the subtelomeric portion, in correspondence of the CpG islands 
(Luke and Lingner 2009). These islands are maintained non-methylated from the 
intervention of the insulator proteins CTCF and cohesin, to allow the transcription of 
TERRA (Ng et al. 2009). TERRA exerts several protective functions towards telomeres. 
When telomeres shorten, the heterochromatin histone marks are lost as well as the DNA 
methylation. In this context, TERRA molecules expression is induced. TERRA clusters 
on shortened telomeres (Yu, Kao, and Lin 2014) from which it was originated, acting as 
a signaling molecule with multiple functions. One effect is the recruitment, on that site,  
of the telomerase during S phase (Cusanelli, Romero, and Chartrand 2013), so that 
telomerase can elongate short telomeres and consequently TERRA levels decrease at 
these sites (Porro et al. 2010). 
An additional effect of TERRA is the stabilization of the telomeric complex and the 
maintenance of the heterochromatin (Deng et al. 2009). TERRA interacts with TRF1 and 
TRF2 with a stabilizing effect, moreover, TERRA also binds to methylated histone 
H3K9me3 and participates in heterochromatin formation (Deng et al. 2009). Thus, 
TERRA acts as a scaffold molecule that promotes the recruitment of various proteins at 
the telomeric level. Moreover, the presence of TERRA is required to properly cap the 
telomeres. TERRA is able to bind hnRNPA1, a ribonucleoprotein that in S phase is 
brought in proximity of telomeres (López de Silanes, Stagno d’Alcontres, and Blasco 
2010) and here displaces RPA, a ssDNA binding protein which is required to activate 
ATR checkpoint. POT1 substitutes RPA on the G-overhang, repressing ATR-mediated 
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DDR at telomeres (Flynn et al. 2011). Due to its complementarity with the C-rich strand, 
TERRA is able to form DNA-RNA hybrids, called R-loops (Arora et al. 2014), involved 
in transcription termination and regulation of gene expression (Ginno et al. 2012). 
Formation of R-loops is strictly controlled and these hybrids are resolved by RNaseH1 
and 2, or unwound by helicases such as Pif1 (Paeschke et al. 2013). R-loops stimulate 
homologous recombination in ALT-positive cells and recruit there the telomerase 
complex in telomerase-positive cells (Arora et al. 2014).  
4.4.3. Telomere interactome and its involvement in 
telomeric DNA repair 
Telomeres are preserved by the shelterin proteins, which ensure protection to the 
chromosome termini. However, the telomeric G-quadruplex represent a vulnerable target 
for oxidation (Fleming and Burrows 2013) and the presence of OG could displace the 
shelterin complex (Opresko et al. 2005). One of the key players responsible for the 
removal of OG is NEIL3, which preferentially processes lesions located in single-
stranded or quadruplex DNA (Zhou et al. 2013). NEIL3 participates in telomere integrity 
maintenance, thanks to the interaction with TRF1 during late S-phase and its absence 
leads to telomeric aberrations (Zhou et al. 2017). It was demonstrated that Ape1 is also 
localized at the telomeric level, where it interacts with TRF2, and this interaction ensures 
the integrity of telomeric DNA (Madlener et al. 2013). In the absence of TRF2, the 
binding of POT1 is increased, to stimulate the endonuclease activity in case of DNA 
damage (Lee et al. 2011; Miller et al. 2012).  
RPA (replication protein A) is another fundamental protein that binds to single stranded 
DNA in eukaryotic cells. Its partial depletion by RNA interference dramatically reduces 
cell proliferation, diminishes DNA synthesis, causes genomic instability, and decreases 
DNA repair (Hass, Lam, and Wold 2012). RPA dynamically interacts with helicases 
belonging to the RecQ family, such as RECQL1, WRN, BLM and FANCJ. Moreover, 
RPA recruits to the site of action also DNA translocases, such as SMARCAL1 that 
indirectly interacts with the helicases to solve the stalling of replication forks (Awate and 
Brosh, Jr. 2017). Furthermore, an important protein involved in telomere homeostasis is 
Rif1 (Rap1-interacting factor 1), which interacts with a component of the shelterin 
complex. In mammals Rif1 is not associated with intact telomeres: the interaction takes 
place in case of telomere shortening or DSB at the telomeric level (de Lange 2005). Rif1 
acts as a mediator of DSB repair pathway choice: the protein is involved in determining 
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the activation of HR or NHEJ (Fontana et al. 2018). As HR requires the commitment of 
the end resection, which is dependent on the cell cycle and CDK activity (Hustedt and 
Durocher 2016), a counterbalance is established between CtIP, which promotes resection 
together with BRCA1, and Rif1 that pairs with 53BP1 (Yun and Hiom 2009). 53BP1 acts 
as a reader of histone marks such as H4K20me2 and H2AK15ub, so it promotes NHEJ 
during G1 and early S phase (Zimmermann and de Lange 2014) together with Rif1 that 
attenuates end resection, though in mammalian cells the mechanism of action has still to 
be elucidated. H/ACA ribonucleoproteins also contribute to the assembly and 
stabilization of telomerase complex and to post transcriptional processing of nascent 
ribosomal RNA and pre-mRNA splicing (Meier 2005). Within these RNPs, NOP10 and 
DKC1 are listed as key telomerase components that handle the effects of oxidative stress 
at the telomeric level. When DKC1 or NOP10 are silenced, the cells produce much lower 
levels of TERC and show a decreased telomerase activity (Lin et al. 2015). Another effect 
of the silencing of these components is the increase of oxidative stress, that reflects on 
the levels of oxidized peroxiredoxin and glutathione. Moreover, cells silenced for NOP10 
or DKC1 are more susceptible to DNA damage. So, the depletion of these RNPs affects 
RNA maturation process and generates oxidative stress, which is a significant factor 
determining telomere shortening (Ibáñez-Cabellos et al. 2018). 
4.4.4. Oxidation damage repair at telomeric structures 
Oxidative damage is quite common at the telomeric level (Park et al. 1992), originating a 
considerable amount of OG. As base oxidation can cause a substantial loss of 
thermostability to the DNA sequence and, possibly, disrupt sheltering protein contacts 
with the telomeres (Opresko et al. 2005), several proteins are involved in the repair of 
such type of lesion. When located in a G-quadruplex structure, oxidation damage is 
handled by NEIL1 and NEIL3 glycosylases (Zhou et al. 2013). It was demonstrated that 
NEIL1 and NEIL3 are able to remove, beyond OG, also hydantoin lesions deriving from 
further oxidation within a Na+-coordinated antiparallel quadruplex (Zhou et al. 2015). In 
the same work the processing of several sequences was investigated, in particular, the 
teamwork of Wallace examined the processing of both telomeric sequences containing 
lesions in different positions, and sequences that are found within the promoter of many 
genes, such as VEGF and c-Myc. In this study, the authors state that OGG1 can process 
OG only when they are located in a duplex substrate, and that Ape1 is able to process 
furan in quadruplex DNA Na+-coordinated (Zhou et al. 2015). The authors conclude 
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hypothesizing a possible involvement of NEIL glycosylases in both telomere 
maintenance and gene regulation. Additionally, NEIL3 interacts also with TRF1, and 
appears to be an essential player ensuring telomere integrity by coordinating the repair of 
oxidation damages, as in the absence of this glycosylase the cells display telomere 
dysfunctions (Zhou et al. 2017). NEIL3 cleaves the damaged base and then recruits the 
LP-BER machinery, included Ape1, to facilitate the repair at telomeric loci (Zhou et al. 
2017). Anyway, the mechanism of action and regulation of Ape1 on telomeric G-
quadruplex structures needs to be further elucidated. 
4.4.5. Role of G-quadruplex in transcription regulation 
Oxidation damage at the level of gene promoters organized as G4 could be taken as a 
transcription activating signal  (Fleming, Ding, and Burrows 2017). When a purine in a 
duplex sequence is oxidized, the repair of this modification creates an AP site that 
decreases the thermostability of the double strand, driving to the formation of a more 
stable quadruplex structure (Fleming, Ding, and Burrows 2017). It was suggested that the 
oxidized guanine-containing tract within the promoter of VEGF gene can be looped out 
from the quadruplex structure so to maintain the G4 folding and to facilitate the repair 
proteins in their activity (Fleming, Ding, and Burrows 2017). Consequently, the presence 
of an oxidized guanine leads to the recruitment of the BER components, but the 
quadruplex folding reduces the processivity of the repair process. As a result, transcription 
machinery is engaged, thus oxidation could be considered an epigenetic-like modification 
driving DNA repair-coupled transcription initiation (Zhou et al. 2015; Fleming, Ding, and 
Burrows 2017). It was confirmed that, when Ape1 idles on the abasic site within a G4, 
the protein activates some transcription factors through its redox domain (Fleming and 
Burrows 2017). The group of Burrows employed a luciferase assay to report the 
transcription of VEGF gene to determine whether the localization of OG on the template 
or the coding strand influences the outcome (Fleming et al. 2017). Depending on the 
strand on which the OG is formed, the effect is activation or repression of translation. In 
particular, if the lesion is located on the coding strand, this reflects on transcriptional 
activation, while if it is positioned on the template strand, transcription is switched off 
(Fleming et al. 2017). The oxidation of guanines seems not to be randomly distributed 
throughout the genome: these events appear to be more frequent at the promoters of 
actively transcribed genes (Zarakowska et al. 2014), and this can regulate their 
transcription. The Burrows teamwork demonstrated that the folding of quadruplexes at 
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the promoter level is the responsible for gene expression depending on the localization of 
the potential quadruplex sequence on the coding versus template strand (Fleming et al. 
2018). They highlighted that the frequency of potential quadruplex-forming sequences 
was 1.8-fold higher in promoters of DNA repair genes, compared to other random genes 
of the human genome, so these secondary structures play a very important role in 
regulating gene transcription (Hänsel-Hertsch et al. 2016; Fleming et al. 2018). 
Employing the luciferase reporter assay, the authors used G4-specific ligands to stabilize 
G-quadruplex structures at the promoter level of NEIL1, NEIL3 and BLM genes. They 
observed that activation of transcription occurred when the quadruplex was formed on 
the coding strand, while G4 structures folded on the template strand interfere with 
transcription, which was down-regulated (Fleming et al. 2018). In this context, the 
oxidation of guanine is defined as a friend and foe signal: when solid tumors grow they 
become hypoxic, inducing oxidative stress. This lead to VEGF activation and 
vascularization to permit tumor expansion (Fleming and Burrows 2017). Thus, OG 
behaves both as an epigenetic-like regulator and an initiator of mutagenesis in this 
scenario. Intertwining between DNA repair and transcription activation is starting to earn 
increasing interest. 
4.5. Ape1 role at the telomeres  
Figure 12 shows the network of proteins that interact with both the telomeric regions and 
Ape1 protein. It includes, besides TRF1, TRF2 and RAP1, components of the shelterin 
complex, some players involved the DNA repair processes like XRCC1, XRCC5, 
XRCC6, FEN1, PCNA, DNA-PK and DDB1 and regulation factors such as MCM4, 
MCM7 and HP1γ, which respectively allow DNA replication initiation and contributes 






It was demonstrated that depletion of Ape1 leads to telomere shortening and losses and 
to a higher rate of chromosome fusions (Madlener et al. 2013) and that Ape1 deficiency 
promotes cell senescence and premature aging features (Li et al. 2018). It was proved that 
a mutant form of Ape1, carrying lysine residues 6 and 7 substituted with alanines, 
mimicking the acetylation of these amino acids, display an in vivo increase in the rate of 
telomeric aberrations, despite maintaining its DNA repair activity (Madlener et al. 2013). 
Within the amino-terminus of the protein, several other residues exist which can be 
acetylated, in particular the lysines in position 27, 31, 32 and 35. Moreover, the 
acetylation status of these lysine residues may be modulated by lysines 6 and 7 (Lirussi 
et al. 2012). It was previously found in our lab that a mutant of Ape1 which carries the 
four cited lysine residues substituted with alanines displays enhanced endonuclease 
activity on double-stranded DNA containing an abasic site (Fantini et al. 2010), but 
reduced ability of recognition and processing of the abasic site on a single-stranded 
substrate (Fantini et al. 2010; Poletto et al. 2013). Moreover, cancer cells that express the 
Figure 12 Protein interactome network of telomeric partners 
The figure shows the cross-talk of proteins that are associated to the telomeric region and that 
belong also to Ape1 interactome. 
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Ape1 mutant, bearing Lys/Ala substitution in the four specified positions (i.e. 
Ape1K4pleA), display a reduced proliferation rate (Lirussi et al. 2012). The role of Lys 27-
35 in the processing of telomeric sequences has not been elucidated yet, so we 
hypothesize that the post-translational modification status of the specified lysines may be 
a mechanism to regulate the enzymatic activity of the protein at the telomeric level. 
As the guanine is the base with the lowest redox potential (Steenken and Jovanovic 1997), 
it is a susceptible target of oxidation. Consequently, the telomeric sequences are 
vulnerable regions and, under oxidative stress conditions, the formation of oxidized and 
abasic sites is frequent. The structure of the quadruplex is highly destabilized by the 
presence of an apurinic site which disrupts the tetrad (Virgilio et al. 2012; Esposito et al. 
2010; Babinský et al. 2014). Ape1 can exert its endonuclease activity in vitro on abasic 
sites located in telomeric repeats-containing double strands (Broxson et al. 2014; Li et al. 
2014; Theruvathu et al. 2014), and also on the quadruplex structure of the c-Myc 
promoter, though with an attenuated cleavage rate (Broxson et al. 2014). It seems that 
Ape1 activity on G-quadruplex structures containing an abasic site is influenced by the 
coordinated cation, which may induce a different folding (Zhou et al. 2015). As 
mentioned before, Ape1 stalling on a G4 while processing the abasic site here located 
may induce partial unfolding of the DNA secondary structure to extrude the lesion. 
However, nowadays, little is known about the ability of Ape1 to process abasic sites 







5. Aim of this study  
Cancer cells are frequently characterized by the dysregulation of telomere homeostasis. 
In particular, tumors display aberrations at the telomeric level due to shortened telomeres 
that are illicitly elongated to ensure the maintenance of a required length which allows 
unlimited cellular replication (Hanahan and Weinberg 2011). Moreover, cancer cells 
often exhibit telomeric fusions, bridges, telomeric translocations and breakages. Human 
telomeres are composed of the repeated sequence TTAGGG and are characterized by the 
protrusion of the 3’ extremity (de Lange 2005). The single stranded filament assumes a 
secondary structure called G-quadruplex (G4), thanks to the hydrogen bonds established 
between the guanines. As the guanine is the most susceptible base toward oxidative 
damage (Steenken and Jovanovic 1997), these regions are a hotspot for oxidation. When 
a guanine is oxidized, the modification leads to a lower stability of the G-quadruplex 
(Babinský et al. 2014). Base excision repair is active also at the telomeric level, where 
ensuring the maintenance of integrity is crucial for cellular proliferation. A key player of 
the BER is Ape1, the major human endonuclease (Hadi et al. 2002). Recently it was 
shown that Ape1 presence is fundamental in the maintenance of telomere physiology 
(Madlener et al. 2013), however the details regarding the molecular regulation of its 
enzymatic activity have not been elucidated yet. 
We already investigated the Ape1 ability to process single-stranded nucleic acids that 
resulted strictly dependent on the propensity of the substrate to adopt secondary structures 
and is modulated by the N-terminal basic unstructured portion of the protein (Poletto et 
al. 2013). Here, we want to shed light on the role of the N-terminal arm of Ape1 for the 
stable recognition and enzymatic processing of telomeric substrates. We particularly 
focused on the function of lysine residues, which can be modulated through acetylation, 
that represents a mechanism to regulate the affinity of the protein toward nucleic acids. 
We employed several substrates mimicking the telomeric structure and containing an 
abasic site analog located in different positions to perform endonuclease activity assays 
in two different saline conditions with several Ape1 protein mutants mimicking 
acetylation of crucial lysine residues within N-terminal domain.  
Understanding the inherent need for Ape1 at telomeres is critical to define the precise 





6.1. Structural analysis of G4 sequences by circular dichroism 
(CD) spectroscopy 
Previous studies, performed on dsDNA, demonstrated that Ape1 exhibits a substrate-
dependent endonuclease activity (Berquist, McNeill, and Wilson III 2008; Marenstein, 
Wilson III, and Teebor 2004) and may play a role in telomere maintenance (Madlener et 
al. 2013). The potential of Ape1 to process telomeric G-quadruplex structures containing 
abasic sites has been barely investigated (Madlener et al. 2013; M. Li et al. 2018; Zhou 
et al. 2015; Fleming, Ding, and Burrows 2017). In order to fill in this gap, we used three 
labelled oligonucleotides (ODN) (Table 1), including telomeric sequences already known 
to fold into G4 structures (Virgilio et al. 2012), some bearing abasic sites in different 
positions. Specifically, the ODN, indicated as S4 and S8 contain a tetrahydrofuran (F) 
residue resembling an abasic site (Takeshita et al. 1987), replacing the 4th or the 8th 
guanosine, respectively, while Nat represents the natural telomeric sequence containing 
undamaged DNA. In order to obtain structural insights, we first analyzed the ODN by CD 
spectroscopy, under several buffer conditions including those required for the enzymatic 
assays. The profile of the labeled Nat sequence (Figure 13 A) (annealed at 70 mM KCl) 
appears almost superimposable on that of its unlabeled counterpart (Virgilio et al. 2012), 
thus indicating that the presence of the IRDye moiety does not influence G-quadruplex 
conformation. This profile is characteristic of the hybrid 3+1 strand arrangement (Dai, 
Carver, and Yang 2008). On the other hand, the CD spectrum of sequence S4 (Figure 13 
B) shows a positive band around 265 nm, typical of parallel G-quadruplexes, and a further 
positive band at 295 nm. In turn, S8 exhibits a negative band at 243 nm and a positive 
band at 265 nm (Figure 13 C), that are characteristic of parallel G-quadruplex structures 
adopted by telomeric sequences in molecular crowding conditions (Heddi and Phan 
2011). These data would suggest the coexistence of parallel and other types of G-
quadruplex conformations for S4 and S8, with a clear prevalence of the parallel 
conformation in the case of S8 (Virgilio et al. 2012). Overall, the CD profiles of the three 
labeled ODN in the conditions tested appear very similar to those obtained in KCl 70 mM 
solution alone, thus indicating that the changes of buffer composition, due to addition of 
Tris and MgCl2, and KCl, do not affect the G-quadruplex folding topology adopted 
following the annealing procedure. Schematic representations of the hybrid 3+1 
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conformation, adopted by Nat, and that of the parallel G-quadruplex are reported in Figure 





Figure 13 CD spectroscopy of the oligonucleotides used in this study 
Overlay of CD spectra of telomeric oligonucleotides Nat (A), S4 (B) and S8 (C) acquired at 





Figure 14 Schematic representations of G-quadruplex structures assumed by the 
oligonucleotides used in this work 
Hybrid G-quadruplex (left, Nat, and center) formed by the original sequence and the parallel G4 
(right) adopted in molecular crowding conditions. Guanosines adopting anti and syn glycosidic 
conformations are indicated in blue and orange, respectively. S4 and S8 indicate the positions in 
which abasic sites have been introduced. For clarity, the loop residues have been omitted. 
 
CD-melting experiments were also carried out to investigate the thermal stability of the 
G-quadruplex structures adopted by the labeled ODN at the lowest salt concentration, 
namely the least favorable conditions for the G-quadruplex stability. The CD-melting 
profiles (Figure 15) showed that all the G-quadruplex structures start to melt at around 
45-50°C and thus the three ODN were completely folded at 37°C. These data clearly 
indicate the presence of suitable amount of G-quadruplex structures in all the conditions 
used for the following assays. 
 
Figure 15 Circular dichroism (CD) analysis for the G4 oligonucleotides used in this study 
CD melting profiles of each telomeric oligonucleotide acquired at the maximum CD λ values for 




6.2. The 33-residue Ape1 N-terminus is required to stably 
bind telomeric G4 structures  
The 33 N-terminal residues of Ape1 play a role in the recognition of single stranded 
nucleic acids (Poletto et al. 2013). Therefore, we analyzed the functional role of this 
domain of Ape1 for interaction with telomeric sequences. The recombinant proteins used 
here (unmodified Ape1 or Ape1WT, and a derivative lacking the first 33 N-terminal 
residues called Ape1N∆33) were expressed and purified in E. coli as previously described 
(Fantini et al. 2010) and verified by SDS-PAGE analysis (Figure 16). 
 
The binding ability of purified recombinant Ape1 proteins to the ODN was tested through 
electrophoretic mobility shift assay (EMSA) analyses (Figure 17). These assays were 
performed by incubating the proteins with the telomeric substrates (i.e. Nat, S4 and S8) 
and the unstructured Poly dT-F, a poly dT oligonucleotide containing an abasic site, as a 
control. The analysis of native gels (Figure 17, left) revealed that Ape1WT bound the 
telomeric sequences whereas this ability was lost when the N-terminal domain was 
missing. Specifically, three different shifted bands (indicated by asterisks in the figure) 
are clearly visible that correspond to protein-DNA complex formation between Ape1WT 
and the telomeric sequences (lanes 2, 4, 6). Lower bands, with weaker intensities, may 
have increased mobility due to conformational differences (Kladova et al. 2018). As 
Figure 16 Gel analysis of purified human recombinant proteins used in this study 
Proteins were separated onto 10% SDS-PAGE followed by Coomassie brilliant blue staining. 5 
µg loaded of each bacterial lysate (“NI” means not IPTG-induced bacteria and “Ind” means I 
means IPTG-Induced bacteria); 0.5 µg Loaded of each purified protein. The molecular weight 
(MW) is expressed in kilodaltons (kDa). 
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expected, there was no indication of complex formation between Ape1 and the 
unstructured Poly dT-F (lane 8), confirming the importance of ODN secondary structure 
for stable binding (Poletto et al. 2013). Furthermore, the band pattern among the three 
ODN demonstrated that Ape1WT is proficient in binding the G-quadruplex sequences with 
no significant differences among the G4 substrates used. In addition, EMSA experiments 
with the Ape1N∆33 (Figure 17, right) highlight the requirement of the 33 N-terminal 
domain residues for binding to each G4 substrate (lanes 3-5-7). Again, no detectable 
complex was observed for the unstructured Poly dT-F (lane 9) incubated with Ape1N∆33.  
Notably, UV-crosslink experiments (Figure 18) showed that the more stable complex 
between Ape1 and the substrate has relative mobility corresponding to ~44 kDa in the 
case of the Ape1WT protein, and of about 42 kDa in the case of the Ape1N∆33 deletion 
mutant, consistent with a 1:1 stoichiometry in the complex. Moreover, the presence of a 
UV-crosslinked complex between Ape1N∆33 and the ODN (Figure 18) suggests that the 
 
Figure 17 Ape1 stably binds the G4 oligonucleotides 
Representative native EMSA polyacrylamide gel of recombinant Ape1WT (left) and Ape1NΔ33 
(right). Binding on the indicated ODN substrates (25 nM) is shown. Poly dT-F was used as 
negative control whereas Nat was used as positive control. The difference between this signal 
and the corresponding sample in the left panel relies only the intensity. *, ** and *** indicate 
the signals derived from metastable complexes that display different migration. Reactions were 




absence of the 33 N-terminal domain does not hamper the ability of the protein to interact 




Altogether, these results demonstrated that: i) the molar ratio between the protein and the 
substrate is close to 1:1 as detected by the calculated molecular weight of the Protein-
DNA complexes through UV-crosslink experiments; ii) the different mobility of the 
complexes and the weak signals of the retarded complexes, as seen from EMSA 
experiments, is possibly due to metastable complexes formation during the 
electrophoretic run (Kladova et al. 2018) and iii) the absence of the 33 N-terminal domain 
may probably affect the binding equilibrium of Ape1 with the substrate, possibly 
accelerating the dissociation step.  
Figure 18 Cross-linking analysis performed with Nat oligonucleotide 
The substrate was challenged with Ape1WT (lane 3) or Ape1NΔ33 (lane 4) as described in Materials 
and methods section. Reactions were resolved onto SDS-PAGE 10%. Lane 1 and 2: non-
crosslinked or crosslinked Nat ODN respectively. Lane 5 and 6: Ape1WT and Ape1NΔ33 respectively 
crosslinked without Nat. 
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In order to quantitatively evaluate the affinity of both Ape1WT and Ape1N33 for the 
telomeric Nat sequence, we used surface plasmon resonance (SPR) analyses. The 
overlays of the binding profiles are shown in Figure 19 (and in Figure 20). Both proteins 
exhibited concentration-dependent binding: whereas Ape1WT exhibited a low nanomolar 
value for its dissociation constant with the Nat sequence (Figure 19, left), the binding of 
Ape1NΔ33 to the Nat sequence (Figure 19, right), exhibited a 9-fold reduced affinity (KD) 




















Nat 8.23 2.6 31.6 
Poly dT 2.82 4.79 170 
NPM1 
Nat 2.022.042.04 2. 2.9999 11477 




Nat 3.04 8.67 285 
Poly dT Not valuable 
Table 1 SPR based equilibrium dissociation constants (KD) and kinetic parameters for the 
interaction of Ape1WT and Ape1NΔ33 and NPM1 with Nat and Poly dT ODN using the 
BIAevaluation v.4.1 software. Data reported were obtained through SPR analyses using proteins 
as analyte on the indicated biotinylated ODN ligands. 
Figure 19 SPR sensorgrams for Ape1WT and Ape1NΔ33 with Nat oligonucleotide 
Overlay of sensorgrams relative to SPR experiments for the binding to immobilized Biot- Nat of 
Ape1WT (left) and Ape1NΔ33 (right), respectively. 
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This was further corroborated by the SPR analysis of Poly dT/Ape1NΔ33 interaction, that, 
in the range of concentrations tested, does not allow the evaluation of the KD value (Figure 
20); while Ape1WT shows an affinity toward this unstructured ligand five-fold reduced 
with respect to the G-quadruplex sequence (Table 2). The absence of a visible signal 
arising from the interaction between Ape1NΔ33 and Nat substrate in EMSA assay, despite 
a five-fold difference in KD with respect to Ape1
WT, may be due to the shifting of the 
equilibrium during the electrophoretic run toward the dissociated form of the complex. 
These data further confirm the crucial role exerted by the N-terminal region of Ape1 in 
the recognition of the G4 ODN, reflected in both dissociation and association phases 
shown by Ape1NΔ33 with respect to full-length (Table 2).  
 
6.3. The enzymatic activity of Ape1 on G4 telomeric 
structures is influenced by ionic strength and the N-
terminus 
In order to test the endonuclease activity of Ape1 on telomeric substrates, we performed 
AP-site incision assays under different salt concentrations including, as substrate, a 
conventional dsDNA oligonucleotide containing an abasic site in the middle, named ds-
F (Sanderson et al. 1989). 
Cleavage assays were performed by incubating the indicated amounts of Ape1WT with a 
fixed amount of each G4 substrate in a high ionic strength solution (50 mM KCl). As 
Figure 21 shows, Ape1WT exhibited different endonuclease activities on the three 
substrates: it did not significantly cleave the S4 ODN, generating a maximum of only 
about 4% of product. In contrast, Ape1 cleaved about one third of the S8 ODN substrate 
at the highest protein concentration (Figure 21).  
Figure 20 SPR sensorgrams for Ape1WT and Ape1NΔ33 with Poly dT oligonucleotide 
Overlay of sensorgrams relative to SPR experiments for the binding to immobilized Biot- Poly dT 




Figure 21 The position of the abasic site on the G4 influences Ape1WT endonuclease activity 
Representative denaturing polyacrylamide gels of AP site incision by Ape1WT on S4 and S8 
incubated with the indicated amount of protein in a solution containing 50 mM KCl as described 
in Materials and methods section (left). Graph describes the percentage of conversion of substrate 
(S) into product (P) as a function of the dose of Ape1 protein on the specified substrate (right). 
ds-F ODN was used as positive control. S denotes the substrate position; the length of the 
generated products is 1 nt different between S8 (P) and ds-F (P’). Average values are plotted with 
standard deviations of three loadings of the same experiment as a function of protein dosage. 
Standard deviation values were always less than 10% of the mean of experimental points. 
Asterisks indicate a statistically significant difference between the indicated substrate and Poly 
dT-F oligonucleotide processing. 
 
As expected, the Poly dT-F was cut less efficiently than S8, as it does not adopt secondary 
structures, and the Nat sequence was not processed (Figure 22). Moreover, as expected, 
the ds-F ODN was the best substrate, with a 1000-fold higher rate of cleavage by Ape1 




Prompted by the importance of the Ape1 N-terminal domain in binding G4 structures 
(Figures 13 and 17), we analyzed the endonuclease activity of the Ape1NΔ33 on the same 
telomeric substrates (Figure 23). At high ionic strength (i.e. 50 mM KCl), Ape1NΔ33 
cleaved the G-quadruplex structures much less efficiently than Ape1WT protein. Cleavage 
of the S8 substrate reached a maximum of nearly 15%, while both the S4 and Poly dT-F 
ODN gave maxima of only about 1% product (Figure 23).  
Figure 22 Ape1WT endonuclease activity on control substrates 
Representative denaturing polyacrylamide gels of AP site incision by Ape1WT on the indicated 
oligonucleotides incubated with the specified amount of protein in a solution containing 50 mM 
KCl as described in Materials and methods section (left). Graph describes the percentage of 
conversion of substrate (S) into product (P) as a function of the dose of protein on the specified 
substrate (right). ds-F or S8 oligonucleotides were used as positive controls. S denotes the 
substrate position, P denotes the product position. Average values are plotted with standard 
deviations of three loadings of the same experiment. Standard deviation values were always less 




Figure 23 The position of the abasic site on the G4 influences Ape1N∆33 endonuclease activity 
Representative denaturing polyacrylamide gels of AP site incision by Ape1N∆33 on S4 and S8 
incubated with the indicated amount of protein in a solution containing 50 mM KCl as described 
in Materials and methods section (left). Graph describes the percentage of conversion of substrate 
(S) into product (P) as a function of the dose of Ape1 protein on the specified substrate (right). 
ds-F ODN was used as positive control. S denotes the substrate position; the length of the 
generated products is 1 nt different between S8 (P) and ds-F (P’). Average values are plotted with 
standard deviations of three loadings of the same experiment as a function of protein dosage. 
Standard deviation values were always less than 10% of the mean of experimental points. 
Asterisks indicate a statistically significant difference between the indicated substrate and Poly 
dT-F oligonucleotide processing. 
 
The activity of Ape1NΔ33 on ds-F, was weaker than that of the full-length protein but, at 
the highest concentration, Ape1NΔ33 was able to process nearly all the substrate, with no 




At low ionic strength, the Ape1 N-terminus affects the catalytic activity of the protein, 
via the product-release step of the reaction (Fantini et al. 2010). We therefore tested the 
effects of reduced salt concentration on Ape1-cleavage activity, by performing enzymatic 
experiments in 5 mM KCl (vs. 50 mM in the previous experiments). Under these 
conditions, Ape1WT displayed increased endonuclease activity on G4 structures (Figure 
25), then seen at higher KCl (Figure 21).  
Figure 24 Ape1N∆33 endonuclease activity on control substrates 
Representative denaturing polyacrylamide gels of AP site incision by Ape1N∆33 on the indicated 
oligonucleotides incubated with the specified amount of protein in a solution containing 50 mM 
KCl as described in Materials and methods section (left). Graph describes the percentage of 
conversion of substrate (S) into product (P) as a function of the dose of protein on the specified 
substrate (right). ds-F or S8 oligonucleotides were used as positive controls. S denotes the 
substrate position and P denotes the product position. Average values are plotted with standard 
deviations of three loadings of the same experiment. Standard deviation values were always less 
than 10% of the mean of experimental points. 
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In detail, the S4 resulted to be better processed under low ionic strength conditions (Figure 
25) by Ape1WT, with an increase of about ten-fold with respect to high salt concentration 
(50 mM KCl). Similarly, the S8 appeared more efficiently processed at low ionic strength 
Figure 25 Ape1WT cleaves AP sites in G4 substrates more efficiently at lower ionic strength 
Representative denaturing polyacrylamide gels of AP site incision by Ape1WT on the indicated 
substrates with the indicated amount of protein in a solution containing 5 mM KCl as described 
in Materials and methods section; ds-F or S8 were used as positive control (left). Graph depicting 
AP site incision activity of Ape1WT on the specified substrate in a solution containing 5 mM KCl. 
Graph describes the percentage of conversion of substrate (S) into product (P) as a function of 
the dose of protein on the specified substrate. Average values are plotted with standard deviations 
of three loadings of the same experiment as a function of protein dosage. Standard deviation 
values were always less than 10% of the mean of experimental points. Asterisks indicate a 
statistically significant difference between the indicated substrate and Poly dT-F oligonucleotide 
processing. 
Figure 26 Ape1WT cleaves AP sites in ds substrates more efficiently at lower ionic strength 
Representative denaturing polyacrylamide gel of AP site incision by Ape1WT on ds-F substrate 
(left). The substrate was incubated with the indicated amount of Ape1 in a solution containing 5 
mM KCl as described in Materials and methods section. S denotes the substrate position and P 
denotes the product position. Graph describes the percentage of conversion of substrate (S) into 
product (P) as a function of the dose of protein on ds-F (right). Average values are plotted with 
standard deviations of three loadings of the same experiment. Standard deviation values were 
always less than 10% of the mean of experimental points. 
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with a more than two-fold increase in product formation. Notably, also the Poly dT-F was 
processed under these conditions, with an efficiency similar to that displayed on the S8 
(Figure 25). As expected for ds-F, the efficiency was significantly higher (about 100-
fold), compared to the two G4 structures (Figure 26), and 4-fold higher with respect to 
the activity measured at 50 mM KCl. Therefore, the Ape1 enzymatic activity was 
significantly affected by the KCl concentration and it was modulated by an electrostatic 
effect possibly involving the contribution of the basic amino acids of the N-terminal arm 
(Fantini et al. 2010; Poletto et al. 2013).  
Then, also the activity of Ape1N∆33 was tested under low ionic strength conditions. Both 





Figure 27 Ape1N∆33 cleaves AP sites in G4 substrates more efficiently at lower ionic strength 
Representative denaturing polyacrylamide gels of AP site incision by Ape1N∆33 on the indicated 
substrates with the indicated amount of protein in a solution containing 5 mM KCl as described 
in Materials and methods section; ds-F or S8 were used as positive control (left). Graph depicting 
AP site incision activity of Ape1N∆33 on the specified substrate in a solution containing 5 mM KCl. 
Graphs describe the percentage of conversion of substrate (S) into product (P) as a function of 
the dose of protein on the specified substrate. Average values are plotted with standard deviations 
of three loadings of the same experiment as a function of protein dosage. Standard deviation 
values were always less than 10% of the mean of experimental points. Asterisks indicate a 




Moreover, the activity of Ape1NΔ33 on ds-F was even higher than the one displayed by 
Ape1WT protein (Figures 28), since the maximum product formation is reached at 1.5 fmol 
of Ape1NΔ33. These data are in agreement with previous results and are due to an increase 
of the koff in the catalytic reaction (Fantini et al. 2010).  
 
In order to evaluate the dependence of the Ape1 activity on ionic strength, we analyzed 
the variation of enzyme products formation by Ape1WT and Ape1NΔ33 on the S8 substrate, 
as a function of KCl concentrations (Figure 29). Data obtained clearly indicated a linear 
dependence of the Ape1 endonuclease activity on KCl concentrations even though to a 
different extent for the two proteins since the trend line of Ape1NΔ33 showed a greater 
steepness (m= -1.574) with respect to that of Ape1WT (m= -1.136).  
Figure 28 Ape1N∆33 cleaves AP sites in ds substrates more efficiently at lower ionic strength 
Representative denaturing polyacrylamide gel of AP site incision by Ape1N∆33 on ds-F substrate 
(left). The substrate was incubated with the indicated amount of Ape1 in a solution containing 5 
mM KCl as described in Materials and methods section. S denotes the substrate position and P 
denotes the product position. Graph describes the percentage of conversion of substrate (S) into 
product (P) as a function of the dose of Ape1N∆33 on ds-F (right). Average values are plotted with 
standard deviations of three loadings of the same experiment. Standard deviation values were 




In Figure 30, the quantifications of the amount of products obtained under the different 
salt concentration conditions, as above, are summarized showing that the dependence of 
the enzymatic activities of Ape1WT and Ape1NΔ33 proteins on salt concentrations appeared 
more pronounced for S4 and the S8 ODN with respect to the ds-F substrate.  
 
Overall, these data demonstrated that the enzymatic activity of Ape1 on G4 telomeric 
structures strongly depends on the ionic strength and on the presence of the N-terminal 
unstructured domain. Therefore, these findings suggest that the charged residues present 
in the N-terminus of Ape1 may modulate its enzymatic activity on G4 structures. 
 
Figure 29 Ionic strength influences Ape1 endonuclease activity 
Representative denaturing polyacrylamide gels of AP site incision by Ape1WT or Ape1NΔ33 on S8 
substrate. The substrate was incubated with the indicated amount of Ape1 in a solution 
containing the indicated concentrations of KCl. S denotes the substrate position and P denotes 
the product position (left). AP site incision activity on S8 ODN decreases in raising ionic 
strength. Graph depicting endonuclease activity experiments performed with Ape1WT or Ape1NΔ33 
as described in Materials and methods section. Average values are plotted with standard 
deviations of three loadings of the same experiment as a function of KCl concentration used 
(right). Standard deviation values were always less than 10% of the mean of experimental points. 
Asterisks indicate a statistically significant difference between the endonuclease activity displayed by 
Ape1WT with respect to Ape1NΔ33. 
Figure 30 Summary of AP site incision activity of Ape1 protein on the different substrates 
Histograms summarizing the different endonuclease activities of Ape1WT (left) and Ape1NΔ33 
(right) on the specified substrates at the indicated doses (fmol) of the enzyme in the stated KCl 
concentrations on the different substrates. Each bar was compared with the activity of the 
protein on ds-F in the corresponding saline condition. 
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6.4. Acetylatable lysine residues in the Ape1 N-terminus 
are required for binding and enzymatic activity on G4 
telomeric structures 
In order to investigate whether the positive charges (i.e. acetylatable lysine residues) in 
the Ape1 N-terminal domain might affect the processing of damaged telomeric substrates, 
we evaluated the endonuclease activity on the S4 and S8 substrates of Ape1K4pleA, in 
which replacement of the lysine by alanine residues mimics acetylation by neutralizing 
the positive charges of the side chains (Fantini et al. 2010; Lirussi et al. 2012). 
 
Purified Ape1K4pleA (Figure 31) displayed an altered mobility with respect to Ape1WT, 
which was likely due to the alteration of the overall charge, as we previously observed 
(Fantini et al. 2010). First, we evaluated the ability of Ape1K4pleA to interact with the 
telomeric sequences. UV-crosslinking experiments (Figure 32) demonstrated that all the 
proteins form complexes with both S4 and S8, and that the complexes had the same 
relative mobility as the proteins.  
Figure 31 Purified recombinant Ape1 mutant proteins check 
Gel analysis of human purified recombinant proteins used in this study. 0.5 µg of each protein 




The enzymatic activities were assessed under different salt concentration conditions. At 
50 mM KCl, none of the proteins had strong activity on S4 (<3% product formation). All 
the proteins had some activity on S8 at 50 mM KCl, with Ape1WT having a 2- to 3-fold 
higher rate of cleavage than Ape1N∆33 and Ape1K4pleA (Figures 33 and 34). In contrast, the 
activity of Ape1K4pleA on ds-F at 50 mM KCl resembled that of the Ape1WT, while 
Ape1K4pleA activity was somewhat lower (Figures 33 and 34).  
 
Figure 32 Ape1 interacts with G4 oligonucleotides in a stoichiometric ratio 
Interaction between recombinant wild type and mutant Ape1 with S4 (left) and S8 (right) was 
evaluated through crosslinking analysis. The substrates were challenged with Ape1WT (lane 3), 
Ape1NΔ33 (lane 4) or Ape1K4pleA (lane 5) as described in Materials and methods section. Reactions 
were resolved onto SDS-PAGE 10%. Lane 1 and 2: non-crosslinked or crosslinked ODN 
respectively.  
Figure 33 AP site incision activity graphs summarizing endonuclease activity of Ape1 protein 




At 5 mM KCl, the lower salt concentration strongly increased the activity of all the 
proteins on both the S4 and the S8 substrates (Figure 35 and 36). On the S4 substrate, 
Ape1K4pleA was more active (~44% product) than Ape1WT (Figure 35 and 36). Notably, 
the activity of both modified Ape1 proteins on ds-F was similar and higher than that of 
Ape1WT (Figure 35 and 36). 
 
Figure 34 Endonuclease activity of Ape1K4pleA on telomeric oligonucleotides and control 
substrate at high ionic strength 
Representative denaturing polyacrylamide gels of AP site incision by Ape1K4pleA on the indicated 
substrates with the specified amount of protein in a solution containing 50 mM KCl as described 
in Materials and methods section. 
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Overall, these data clearly demonstrate that lysine 27-35 of Ape1 contribute strongly to 
the binding and cleavage activity of the enzyme for a DNA lesion in telomeric sequences; 
acetylation to neutralize these residues in vivo may modulate Ape1 function at telomeres. 
 
6.5. Activity of Ape1 protein variants from U2OS cells 
The Ape1 enzymatic activity could be dynamically modulated by interacting proteins in 
cells (Vascotto et al. 2014; Moor et al. 2015). With the aim to evaluate the contribution 
of such partners on the enzymatic activity of Ape1, we carried out enzymatic assays 
employing Ape1-protein complexes isolated from human cell lines. In these assays, in 
addition to the K-to-A protein, we introduced the alternative K-to-R protein (a non-
acetylatable form - Ape1K4pleR) and the K-to-Q protein (mimicking a constitutive 
acetylated Ape1 form retaining the side chain with the charge neutralized - Ape1K4pleQ) 
substitutions (Lirussi et al. 2016). We measured the activity of the Ape1 proteins on 
telomeric substrates using immunocaptured Ape1-protein complexes obtained from 
U2OS human cells (Figure 37 and 38). These complexes were affinity purified following 
transfection of vectors expressing the FLAG-tagged mutant proteins (Lirussi et al. 2016) 
Figure 356 AP site incision activity graphs summarizing endonuclease activity of Ape1 protein 
and its mutants on the different substrates in a solution containing 5 mM KCl 
Figure 365 Endonuclease activity of Ape1K4pleA on telomeric oligonucleotides and control 
substrate at low ionic strength 
Representative denaturing polyacrylamide gels of AP site incision by Ape1K4pleA on the indicated 
substrates with the indicated amount of protein in a solution containing 5 mM KCl as described 
in Materials and methods section. 
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and checked for the presence of Ape1’s partners such as nucleophosmin (NPM1) (Figure 
38 and Antoniali et al. 2017).  
The Ape1K4pleA and Ape1K4pleQ proteins obtained from U2OS cells had different 
electrophoretic mobility than Ape1WT (Figure 37), consistent with the recombinant 
proteins obtained from E. coli (Figure 31). The separation of these IP samples on a urea-
gel demonstrated that the altered migration obtained in SDS-PAGE gels was not due to a 
different apparent molecular weight of the mutants Ape1K4pleA and Ape1K4pleQ, but 
Figure 387 Immunocaptured Ape1WT and mutant proteins check 
Western blot analysis of Ape1 IP samples used in this study. Co-IP proteins were separated onto 
10% SDS-PAGE and immunoprobed with anti Ape1 antibody. rApe1 was included for 
comparison. 
Figure 378 Analysis of the interaction between Ape1 mutants and NPM1 
Evaluation of Ape1 IP from U2OS cells overexpressing Ape1 mutants resolved on 10% SDS-
PAGE analyzed through Western blot. Total cell extracts were immunoprobed with anti Ape1 
and anti NPM1 antibodies (First and second panel respectively); each lane of the first panel 
displays a lower band corresponding to the endogenous Ape1 and an upper band corresponds to 
the exogenous flagged protein. Co-IP proteins were immunoprobed with anti NPM1 antibody 
(Third panel) and Ape1 was detected through Ponceau red staining (Fourth panel). 
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presumably to the change of the overall charge (Figure 39), as previously shown (Fantini 
et al. 2010). 
We then conducted UV-crosslinking experiments with these different Ape1 variants and 
Ape1WT, (Figure 40). The ability of each mutant protein to stably interact with the 
substrates was at least comparable to that of the immunocaptured Ape1WT. Interestingly, 
the Ape1K4pleR protein displayed an enhanced binding ability, relative to Ape1WT, with all 
the substrates used in the UV-crosslinking assay (Figure 40, lanes 7).  
 
We performed cleavage experiments, at low KCl concentration (5 mM), to compare with 
Ape1WT the activity of the two acetylation-mimicking proteins (Ape1K4pleA and 
Ape1K4pleQ) and the protein that mimicks non-acetylatable Ape1 (Ape1K4pleR). 
Figure 39 Analysis of gel mobility of Ape1 mutants from IP 
Samples were separated on a 10% SDS-PAGE containing 7 M urea and immunoprobed with 
anti-Ape1 antibody. The altered electrophoretic mobility observed for the Ape1K4pleA and 
Ape1K4pleQ mutant is due to an alteration of the overall charge. 
Figure 40 Eukaryotic mutants of Ape1 are able to bind the telomeric substrates 
Crosslinking analysis of Immunoprecipitated (IP) samples were performed as described in 
Materials and methods section and run onto an SDS-PAGE 10%. Recombinant protein, rApe1WT 
was used as control. 
59 
 
Endonuclease assays (Figure 41 and 42) demonstrated that, particularly with the S8 
substrate, the acetylation-mimicking mutants displayed a higher endonuclease activity 
than did the Ape1WT and Ape1K4pleR proteins, suggesting that the loss of positive charges 
of several Lys residues confers on the enzyme an increased ability to release the product 
upon cleavage, as we previously hypothesized (Fantini et al. 2010).  
The S4 substrate was significantly less processed by all the tested proteins, similarly to 
previous data obtained with recombinant proteins from E. coli with the activities of 
acetylation-mimicking proteins higher than those of the Ape1WT and Ape1K4pleR proteins. 
Similar experiments, performed at 50 mM KCl, indicated that the enzymatic activity of 
the tested proteins was significantly lower under those conditions, as found for the 
purified proteins (data not shown). 
Figure 41 AP site incision activity graphs summarizing endonuclease activity of eukaryotic 
Ape1 protein and its mutants on the telomeric substrates 
Graphs depicting AP site incision activity of IP for Ape1WT, Ape1NΔ33, Ape1K4pleA, Ape1K4pleQ and 
Ape1K4pleR on the specified substrate in a solution containing 5 mM KCl. Graphs describe the 
percentage of conversion of substrate into product as a function of the dose of protein on the 
indicated substrate. Average values are plotted with standard deviations of three loadings of the 




Overall, our data clearly indicate that the acetylation of lysine residues K27-35 is important 
for controlling the overall enzymatic activity of Ape1 on telomeric sequences, as in the 
case for ordinary abasic dsDNA substrates (Fantini et al. 2010).  
 
Figure 42 Endonuclease activity of eukaryotic immunocaptured Ape1 protein and its mutants 
on telomeric oligonucleotides 
Representative denaturing polyacrylamide gels of AP site incision by co-IP samples of Ape1WT 
or the indicated mutants on the specified G4-structured substrates. The substrate was incubated 
with the indicated amount of Ape1-IP in a solution containing 5 mM KCl as described in 




6.6. The telomeric-binding ability of Ape1 depends on K27, 
K31, K32 and K35 residues 
Next, we checked the ability of Ape1 wild-type and mutated proteins to physiologically 
interact with telomeres by using Telomeric-Chromatin Immuno-Precipitation analysis 
(Telo-ChIP) analyses (see Materials and methods). Telo-ChIP analysis was performed on 
HeLa cells stably expressing FLAG-tagged Ape1 mutant proteins in place of the 
endogenous wild-type (which was down-regulated through a specific siRNA (Lirussi et 
al. 2012; Vascotto et al. 2009; Antoniali et al. 2017)). The expression levels of the ectopic 
forms of Ape1 in these cells was similar to that of the endogenous protein (Antoniali et 
al. 2017), which should minimize off-target and other confounding effects of 
overexpression. The DNA recovered from the ChIP assay was then analysed by 
quantitative PCR (Q-PCR). As shown in Figure 43, the telomeric binding ability of 
Ape1NΔ33 was considerably reduced, compared to Ape1WT protein. In contrast, Ape1K4pleA 
showed a binding ability comparable to that of Ape1WT while Ape1K4pleR bound telomeric 
DNA with an activity 9-fold higher than that of Ape1WT. These data are consistent with 
the binding detected using UV-crosslinking (Figure 32). 
 
Figure 43 Analysis of binding of Ape1 protein and its mutants on telomeric sequences 
U2O2 cells were transfected with pCMV plasmids for the expression of Flag-tagged Ape1 
mutants as indicated in Materials and methods section. Empty vector used as control. Histogram 
shows the amount of telomeric sequences by each mutant of Ape1 resulting from ChIP 




6.7. Interaction of NPM1 with Ape1 modulates its 
endonuclease activity on telomeric sequences 
Since the N-terminal domain of Ape1 is involved in modulating protein-protein 
interactions (Poletto et al. 2013), we next checked whether the interaction with a known 
Ape1 partner NPM1 (Vascotto et al. 2009) may affect Ape1 enzymatic activity on 
telomeric DNA. We previously demonstrated that stable interaction between Ape1 and 
NPM1 requires charged K27-35 residue on Ape1 (Lirussi et al. 2012), and that this 
interaction modulates Ape1 endonuclease activity in vitro and in cancer cells (Vascotto 
et al. 2014). Interestingly, NPM1 can bind G-quadruplex structures in the c-Myc promoter 
(Federici et al. 2010). 
First, we checked whether NPM1 affects telomere physiology by testing whether 
telomere length is affected in the OCI/AML3 cell line, which stably expresses the aberrant 
NPM1c+ protein, which is localized to the cytoplasm, compared to OCI/AML2 cells 
expressing wild-type NPM1 localized to the nucleus (Tiacci et al. 2012). Telomere-length 
assays clearly demonstrated an evident shortening of telomeres in OCI/AML3 cells with 
respect to control OCI/AML2 cells, confirming a role for nuclear NPM1 in telomere 
maintenance (Figure 44, left). To verify the importance of Ape1 role in the maintenance 
of telomere integrity, we inhibited the Ape1 endonuclease activity treating OCI/AML2 
cells with sublethal doses of compound #3 for one week (Rai et al. 2010). Upon the 
inhibition of Ape1 activity, we could detect a shortening of the telomeric signal, as the 
mean telomere length was 3.12 kbp compared with 3.28 kbp of the control sample 
(DMSO). This evidence suggests that the protein exerts its endonuclease activity at the 
telomeric level and its inhibition indeed affects telomere dimension. In order to confirm 
a role for Ape1 in telomere maintenance, we performed the telomere length analysis in 
CH12F3 cells, a mouse lymphoma cell line devoid of Ape1 (∆∆∆) or retaining one copy 
of Ape1 gene (∆++) (Masani, Han, and Yu 2013). The Ape1-proficient line had a 
telomere length averaging ~18 kbp, as expected for mouse telomeres. The Ape1 deficient 
cells showed a significantly shorter telomeres averaging 14 kbp (Figure 44, right). These 
results show a role for Ape1 in telomere maintenance in murine lymphocytes, consistent 




We then investigated the effects of NPM1 on Ape1 binding of the telomeric Nat substrate 
by EMSA assays. NPM1 did not form detectable complexes with the Nat, while there 
clearly was binding by Ape1 (Figure 45, lanes 2 and 3). When increasing amounts of 
NPM1 were added to reactions with a constant amount of Ape1, the extent of the protein-
telomeric DNA complex was progressively decreased (Figure 45, lanes 4-7). As expected, 
Ape1NΔ33 did not form detectable complexes with the Nat sequence, independently of 
NPM1 presence (Figure 45, lanes 8-12). GST-pulldown experiments (Figure 46) 
Figure 44 Ape1 presence is fundamental to maintain telomere integrity in vivo 
Telomeric length assay as a function of NPM1 localization (left). Telomere length assay was 
performed as described in Materials and methods section on acute myeloid leukemia (AML) cells 
showing the different length of telomeres in cell types characterized by different NPM1 
localization. AML2 cells were untreated (UNT) or treated with compound #3 or DMSO. 
Telomeric length assay as a function of Ape1 expression level (right). Telomere length was 
assayed on mouse CH12F3 cells expressing (∆++) or depleted for Ape1 (∆∆∆) protein. Ctrl 
refers to a DNA control with a mean length of 7.4 kbp provided by the kit. The molecular weight 
marker (m) is provided by the kit; the weight of each band is indicated as kbp. 
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confirmed the interaction of Ape1 with NPM1 recombinant proteins under these 
conditions.  
 
The reported ability of NPM1 to bind G-quadruplex structures (Gallo et al. 2012; Federici 
et al. 2010; Scognamiglio et al. 2014) prompted us to investigate telomere binding using 
SPR. As shown in Figure 47, NPM1 does interact with the Nat, although with a 4.6-fold 
lower affinity than Ape1WT (Table 2), consistent with the EMSA results (Figure 45). 
 
Figure 45 NPM1 inhibits Ape1 endonuclease activity competing with the substrate for the 
interaction with the N-terminal domain of the endonuclease 
Representative native EMSA polyacrylamide gel of recombinant Ape1WT and Ape1NΔ33 pre-
incubated with increasing concentrations of NPM1. Binding on Nat substrate (25 nM) is 
shown. Reactions were performed as explained in Materials and methods section. 
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We then analysed the effect of the interaction with NPM1 on the Ape1-AP endonuclease 
activity. When NPM1 was present in a sub-stoichiometric ratio with respect to Ape1, the 
endonuclease activity was modestly enhanced; in contrast when NPM1 was present in a 
supra-stoichiometric ratio with Ape1, the endonuclease activity was inhibited ~2-fold 
(Figure 48). Frome these data, we can conclude that interaction of NPM1 with Ape1 
modulates its endonuclease activity on telomeric sequences, at least in vitro. 
 
Figura 47 GST pull-down experiment showing that NPM1 is able to interact with Ape1 under 
physiologic conditions 
GST pull-down assay was performed as described in Materials and methods section using 
GST or GST-tagged recombinant Ape1WT as the bait and NPM1 as the prey. After the 
incubation, the samples were loaded on a 10% SDS-PAGE and subsequently 
immunoprobed with anti-GST and anti-NPM1 antibodies. 
Figura 46 NPM1 shows only a weak affinity toward Nat substrate 





Figura 48 NPM1, when present in a supra-stoichiometric ratio with Ape1, inhibits its 
endonuclease activity 
Representative denaturing polyacrylamide gel of AP site incision by Ape1WT on S8 substrate in 
the presence of increasing amounts of NPM1 (left). The proteins were incubated in a solution 
containing 50 mM KCl as described in Materials and methods section. S denotes the substrate 
position and P denotes the product position. Histogram showing the level of substrate processing 
upon the increasing ratio between NPM1 and Ape1WT (right). Average values with standard 




This work was aimed at characterizing the ability of Ape1 to recognize and process 
telomeric DNA substrates containing abasic sites in different positions. Moreover, we 
wanted to evaluate the role of the unstructured N-terminal domain and, in particular, that 
of the acetylatable Lys residues we previously identified (Fantini et al. 2010; Lirussi et 
al. 2012). To this end, we analyzed the ability of the wild type and several mutant forms 
of Ape1 to recognize and process different oligonucleotides that are able to fold into 
different G-quadruplex structures. 
We found that Ape1WT was able to bind each G4 structured ODN, independently of the 
presence of the abasic site (Table 1 and Figures 17 and 19). KD values obtained through 
SPR assays showed that the affinity of the protein toward the G4 structured substrates 
was considerably higher than that for an unstructured substrate, highlighting the 
importance of DNA secondary structure for recognition by Ape1, as we previously 
suggested (Poletto et al. 2013). 
While the G-quartet structure appears to be an important determinant, a possible effect of 
the abasic site position on Ape1 activity cannot be ruled out. In fact, the enzymatic activity 
on S4 was significantly lower than that on the S8 substrate, and the CD data indicate that 
the solution composition of G4 structures for S4 and S8 is different. There was a clear 
preference of Ape1 for a parallel G4 structure for S8, with this conformation the one 
preferred under molecular crowding conditions. Consistent with our results, other studies 
report a dependence of Ape1 activity on the type of G4 structure in telomeric sequences 
containing abasic sites (Zhou et al. 2015). Since the variation of ionic strength plays a 
crucial role in similar enzymes (Correa et al. 2013; Abeldenov et al. 2015), we evaluated 
the enzymatic activity of Ape1WT under KCl concentrations of 5-50 mM. There was only 
a small effect of KCl for Ape1 acting on canonical abasic dsDNA (Figures 33 and 35), as 
previously shown (Fantini et al. 2010); the KCl concentration does not affect the 
secondary structure of the G4-substrates (Figure 13). Remarkably, Ape1N∆33 was not able 
to form any stable complexes with the substrates (Figures 17 and 19) and exhibited a 
significantly lower efficiency in processing the abasic lesions in both the S4 and S8 
structures (Figure 23), despite active Ape1 binding as demonstrated by UV-crosslinking 
experiments (Figure 18). These findings further indicate that the unstructured N-terminal 
tail of Ape1, though not directly participating in the enzymatic activity of the protein, can 
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modulate stable DNA binding by Ape1, as we previously hypothesized (Poletto et al. 
2013) and as recently corroborated by other studies (Kladova et al. 2018). 
The Ape1 N-terminal domain is rich in positively charged amino acids (8 Lys and 2 Arg 
residues); several of these lysine residues (K27, K31, K32, K35) can undergo acetylation in 
cells under genotoxic stress conditions (Fantini et al. 2010; Lirussi et al. 2012). Similarly 
to Ape1N∆33, the mutant Ape1K4pleA, which mimics the acetylated status by replacing all 
four Lys with Ala residues, displayed an endonuclease activity on S4 and S8 that was 
significantly lower than that of Ape1WT. Despite this difference, the Ape1K4pleA did not 
show a reduced ability to bind to G4-DNA (Figure 32). Interestingly, at lower ionic 
strength, the activity of the Ape1K4pleA and Ape1NΔ33 mutants was higher than that of 
Ape1WT protein. This result indicates that additional charged amino acids outside the N-
terminus may contribute to the catalytic activities of Ape1. In addition, the increased 
enzymatic activities at low ionic strength of Ape1K4pleA and Ape1K4pleQ on S4 and S8, 
relative to Ape1WT and Ape1K4pleR (Figures 41 and 42), suggest that charged K residues 
in the Ape1 N-terminus may regulate the product-release step, as we previously 
hypothesized (Fantini et al. 2010). These findings are in line with previous observations 
showing that release of the incision product may represent the limiting step in Ape1 
turnover, particularly for dsDNA and structures such as the telomere G-quadruplex 
(Marenstein, Wilson III, and Teebor 2004; Poletto et al. 2013; Mol, Hosfield, and Tainer 
2000; Masuda, Bennett, and Demple 1998). 
The observation that the Ape1K4pleR protein has increased telomere binding ability 
(Figures 40, 41 and 43), also supports the conclusion that the charged residues in the N-
domain significantly contribute to the stability of Ape1-telomeric substrates complexes. 
Recent studies pointed to the unstructured Ape1 N-terminus as a relay for regulating the 
different functions of the protein through modulation of the Ape1-protein interactome 
(Fantini et al. 2010; Vascotto et al. 2014; Antoniali, Lirussi, Poletto, et al. 2014; Antoniali 
et al. 2017). We previously demonstrated that NPM1 stimulates Ape1 endonuclease 
activity on abasic dsDNA in vitro and in cells through interaction with the unstructured 
Ape1 N-terminus (Fantini et al. 2010; Vascotto et al. 2014). Moreover, NPM1 by itself 
interacts with G-quadruplex-forming DNA (Federici et al. 2010), and mouse cells lacking 
NPM1 display general signs of genetic instability and activation of DNA damage 
responses (Colombo et al. 2005). In addition, Acute Myeloid Leukemia (AML)-
associated mutations in the NPM1 gene, cause the re-localization of part of the protein to 
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the cytoplasm (NPM1c+). This mis-localization hampers DNA binding of non-telomeric 
G4 structures by NPM1 (Bañuelos et al. 2013; Chiarella et al. 2013) and may affect Ape1 
nuclear BER function in cancer cells (Vascotto et al. 2014). Therefore, the investigation 
of a potential effect of NPM1 in modulating the activity of Ape1 on G4-structures may 
represent an important model for understanding the role of mutual interactions between 
Ape1 and its interacting partners in the processing of damaged DNA. Using AML cell 
lines, we demonstrated that functional NPM1 is required for maintenance of appropriate 
telomeric length. Depending on the NPM1/Ape1 ratio, recombinant NPM1 may modulate 
the enzymatic activity of Ape1 on abasic telomeric substrates by having a stimulatory 
function under sub-stoichiometric ratio, and an inhibitory effect at supra-stoichiometric 
ratio. It must be noted that functional NPM1 may act as a pentameric molecule (Mitrea et 
al. 2014), so it is possible that, in vivo, a supra-stoichiometric ratio between NPM1 and 
Ape1 may represent a more physiologic condition, though further experiments are needed 
to better circumstantiate these findings in the telomeric context. Overall, the data show 
that, depending on the relative stoichiometric ratio between NPM1 and Ape1, the 
enzymatic activity of Ape1 on telomeric substrates may be strictly modulated by Ape1 
protein interacting partners. Moreover, these findings suggest that an effort should be 
made to directly determine whether telomere maintenance is compromised, as a result of 
disrupting the normal Ape1-NPM1 interaction. 
Since the interaction between NPM1 and Ape1 is also modulated by acetylation of the 
Lys residues at positions 27/31/32/35 (Lirussi et al. 2012), we may also infer that their 
acetylation may significantly affect the Ape1 role on telomere maintenance, not only 
through a direct effect on Ape1 binding on these substrates (Figure 46), but also by means 
of protein-protein mediated effects. Interaction of NPM1 with Ape1 involves mainly the 
N-terminal portion of Ape1 (Poletto et al. 2013) and positive charges on Lys residues at 
positions 27/31/32/35 (Lirussi et al. 2012). Thus, these data support the hypothesis that 
the Ape1 positively charged N-terminus is an important player in regulating the kinetics 
of the interaction of Ape1 with the telomeric substrates. Moreover, the endonuclease 
activity data support the conclusion that, depending on the relative stoichiometric ratio 
between NPM1 and Ape1, the enzymatic activity of Ape1 over telomeric substrates may 
be strictly modulated by Ape1 protein interacting partners. Therefore, these findings 
require an effort to directly determine whether telomere maintenance is compromised, as 
a result of disrupting the functional normal Ape1-NPM1 interaction. 
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Madlener et al. (Madlener et al. 2013) showed that cells expressing an Ape1 mutant 
bearing substitution of K6/K7 with Ala residues underwent severe chromosomal 
instability. Though we did not evaluate the role of these residues in modulating the 
enzymatic activity and binding properties of Ape1 on telomeric G-quadruplex, we may 
speculate that our data might provide the molecular basis for those unexplained findings. 
In fact, we previously found that deacetylation of K6/K7 by Sirtuin 1 (SIRT1) is dependent 
on the charged status of the K27-35 residues (Lirussi et al. 2012). Only when K27-35 are 
positively charged, K6/K7 may be de-acetylated by SIRT1, providing the positive charges 
essential for the normal function of Ape1 at telomeres. These observations support the 
hypothesis that dynamic cross-talk between the Lys residues in the Ape1 N-terminus may 
fine-tune the enzymatic activity of the protein and we speculate that there is a general role 
for acetylation of these residues in regulating Ape1 function at telomeres (Figure 49). 
In another recent work (Kladova et al. 2018), stimulation of the OGG1, MBD4 and ANPG 
glycosylases activities by Ape1 strictly depended on the presence of an intact Ape1 N-
terminus. Through oligomerization of Ape1 along the DNA duplex, which depends on its 
N-terminus, the protein was able to promote DNA-bridges formation and DNA 
aggregation, which, in turn, may cause structural deformation in the DNA double helix 
responsible for increasing the enzymatic rate of the glycosylases themselves. This new 
biochemical property of Ape1 may be particularly interesting in the context of the highly 
repetitive telomeric sequences, in which the secondary and tertiary structures of DNA 
play a fundamental regulatory function that influences genome stability.  
Further studies along these lines are warranted and will deserve particular attention. A 
crystal structure of full-length Ape1 protein with its cognate substrate would provide 
physical evidence to our biochemical observations. To date, all the available crystal 
structures of Ape1 employed an N-terminal truncated form of the protein (Mol et al. 2000; 
Freudenthal et al. 2015), thus limiting definitive conclusions on this unusual DNA repair 
enzyme. 
An altered acetylation status of Ape1 K27-35 has been demonstrated in human cancers 
(Poletto et al. 2012; Bhakat et al. 2016). We may thus hypothesize that chromosomal 
instability in cancer development may result from defective coordination of Ape1 
function at telomeres due to post-translational modifications on its N-terminal Lys 




Figura 49 A model for the regulation of Ape1 activity during the repair of abasic sites in G4 
DNA 
Upon genotoxic damage, the generated damaged base is removed by a BER glycosylase, then the 
abasic site is handled by Ape1. After the intervention of acetyl-transferases, the lysine residues 
located in the N-terminal domain of Ape1 are acetylated. Consequently, this post-translational 
modification induces an increase of the release rate of the product upon the endonucleolytic 
cleavage. Consequently, acetylation may represent an efficient mechanism to regulate the activity 
of the protein also at the telomeric level. 
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8. Future perspectives 
Ape1 N-terminus was defined as an essential domain for the interaction of the protein 
with nucleic acids, modulating the overall affinity of the protein. A recent work showed 
that Ape1, through its N-domain, can polymerize on DNA and that this induces a 
structural deformation of the double strand that could favor the activity of glycosylases 
thus increasing their cleavage rate (Kladova et al. 2018). This new highlighted property 
may be interesting to be further explored when considered in the context of telomeric 
repeats, which are characterized by the presence of secondary structures that influence 
their stability. Therefore, it would be interesting to obtain a crystal structure of the full 
length protein complexed with its substrate, as up to now the crystals were acquired using 
an N-terminal truncated form of the protein (Mol et al. 2000; Freudenthal et al. 2015), so 
partially excluding the contribution of an important functional domain for the enzyme. 
As human cancer cells display an altered acetylation status for lysine residues K27, K31, 
K32 and K35, a correlation between chromosome instability and post translational 
modification dysregulation may exist (Poletto et al. 2012; Bhakat et al. 2016). So further 
investigation of this aspect could allow us to better define the precise association between 
acetylation and Ape1 function at the telomeres with specific in vivo experiments. 
Experiments are underway to better describe the functional role of the N-terminus and for 
the Lysine residues here located in telomere physiology. We are interested in analyzing 
whether telomeres show significant variations in cells expressing these mutant forms of 
Ape1 in place of the wild type protein in term of length, integrity and chromosomal 
aberrations such as translocations or fusions. 
It was demonstrated that Ape1 interacts with TRF2 and that this interaction at the 
telomeric level allows the correct positioning of the shelterin component on the interested 
site (Madlener et al. 2013). Next, it would be useful to assess the interaction between 
Ape1 acetylation mutants and the remaining sheltering proteins to define the interplay 
between the endonuclease and the other components responsible for telomere protection 
and stability.  
Finally, based on the discovery that Ape1 may process abasic RNA, defining the 
interaction between Ape1 and TERRA RNA would be useful to enrich the 
characterization of the interaction of the telomeric transcript and the proteins implied in 
telomeric maintenance. TERRA interacts with TRF1 and TRF2 (Deng et al. 2009), folds 
73 
 
in a parallel G4 structure, participates in 3’ telomeric overhang erosion  (Cusanelli and 
Chartrand 2015) and can form hybrid quadruplexes pairing with complementary DNA 
(Xu and Komiyama 2012). So, this RNA molecule takes active part in several processes 
related with telomere maintenance, heterochromatinization, transcription activation and 
acts as a multiple protein partner and a scaffold that proteins employ to recruit other 
interactors. For these reasons it may have a key role in fundamental cellular processes in 
which also Ape1 takes part. Consequently, the interplay between the endonuclease and 
the telomeric transcript could represent a worthy crosstalk to be studied to better detail 




9. Materials and Methods 
9.1. Protein expression and FPLC purification 
BL21 cells were transformed with the proper pGEX-3X (GST tag) or pET-15b (His tag) 
plasmid following the manufacturer’s instructions. In order to produce the protein, the 
culture was harvested at 37°C at 230 rpm until the reaching of OD600 ~0,7. Finally, the 
culture was induced with 1 mM of IPTG (Sigma) for 4 hours and then was collected upon 
centrifugation. The pellet was lysed in the presence of Protease inhibitor 2.1 mg/ml 
(Sigma) and Lysozyme 0.3 mg/ml (Sigma) through sonication and the sample was 
centrifuged at 23,000 g for 20 minutes at 4° C, then the supernatants were purified through 
the appropriate column for affinity purification. 
GST-tagged proteins (Ape1 WT and mutants) were purified through a GSTrap column 
(GE Healthcare) and they were eluted through at increasing range of GSH (Sigma) 
concentration following the manufacturer’s instructions. Then the proteins were 
incubated with Factor X (Amersham) to remove the tag; the enzyme was separated from 
the protein through a benzamidine column (GE Healthcare) and finally a cation exchange 
purification was performed.  
His-tagged NPM1 protein were purified through a His-Trap column (GE Healthcare) and 
they were eluted through 3 steps at increasing imidazole (Sigma) concentrations. The 
protein was dialyzed and then purified through a cation exchange purification column.  
All protein fractions were stored in a buffer containing 25 mM Tris pH 7.5, 100 mM 
NaCl, 1 mM DTT, 10% glycerol. 
 
9.2. Oligonucleotides synthesis, purification and annealing 
Oligonucleotides (ODN) reported in Table 1 were synthesized on a Millipore Cyclone 
Plus DNA synthesizer using standard solid phase β-cyanoethyl phosphoramidite 
chemistry at 1 µmol scale. The synthesis were performed by using  Fast Deprotection 
DNA 3'-phosphoramidites, a 5'-dimethoxytrityl-3'-phosphoramidite-1',2'-dideoxyribose 
(dSpacer, dS, Link Technologies) for the insertion of an abasic site mimic moiety and 
IRDye 800 phosphoramidite (LI-COR Biosciences) for the introduction of a Near IR 
fluorescent dye at the 5'-end of each ODN sequence. The oligomers were detached from 
the support and deprotected by treatment with concentrated aqueous ammonia in the dark 
for 1.5 hour at room temperature. The oligomers were purified by HPLC (Nucleosil C18 
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column Macherey–Nagel, 100-5; EC250/4.6) using standard methods. The fractions of 
the oligomers were collected and successively desalted by Sep-pak cartridges (C-18). The 
isolated oligomers proved to be >98% pure by HPLC. To perform in vitro experiments, 
some selected ODN sequences used previously (Virgilio et al., 2012) were employed and 
produced homemade as explained in the previous paragraph. A poly dT ODN of 23 bases, 
holding an abasic site (F) in 16th position (Poly dT-F) and an IRDye 800 at the 5’ was 
synthesized by Metabion, purified through HPLC and checked in Mass Check. This probe 
was used as negative control as it is unable to acquire secondary structures. All the ODN 
were resuspended in DNase-free water at 100 µM and annealing was performed at a final 
concentration of 5 µM in a solution containing 70 mM KCl, 20 mM KH2PO4 and 0.2 mM 
EDTA, at pH 7.0, heated at 70°C and cooling down over night. A double-stranded ODN, 
named ds-F, which is composed of 26 bases and it holds a tetrahydrofuran mimicking the 
abasic site in position 15, was also synthesized by Metabion, purified through HPLC and 
checked in Mass Check. This latter ODN was annealed in 10 mM Tris, 10 mM MgCl2, 1 







Nat 5’-TAG GGT TAGG GTT AGG GTT AGG G-3’     - 
S4 5’-TAG GGT TAFG GTT AGG GTT AGG G -3’ 8 nt 
S8 5’-TAG GGT TAGG GTT AGF GTT AGG G-3’ 15 nt 
Poly dT-F 5’-TTT TTT TTTT TTT TTF TTT TTT T-3’ 15 nt 
ds-F 
5’-AAT TCA CCG GTA CCF TCT AGA ATT CG-3’ 
3’-TTA AGT GGA CAT GGG AGA TCT TAA GC-5’ 
14 nt 
Poly dT 5’-TTT TTT TTTT TTT TTT TTT TTT T-3’ - 
Table 2: Sequences of the ODN used in this study 
F: tetrahydrofuran abasic site analog. Nat, S4 and S8 substrates are single strand DNA 
folded in a G-quadruplex. Poly dT-F is an unstructured DNA single strand. ds-F is the 
only duplex DNA sequence. All the ODN are labeled with IRDye 800 at the 5’ end. 
 
9.3. Circular dichroism (CD) spectroscopy 
CD samples of the IRDye-labelled oligonucleotides reported in Table 1 were prepared at 
an ODN concentration of 25 µM by using a potassium phosphate buffer (20 mM 
KH2PO4/K2HPO4, 70 mM KCl, pH 7.0) and submitted to the annealing procedure 
(heating at 70°C and slowly cooling at RT). CD samples at 50 mM KCl were prepared 
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by diluting the samples at 70 mM KCl and adding the suitable amounts of Tris and MgCl2 
to final concentrations of 50 mM and 10 mM, respectively. CD samples at 5 mM KCl 
were prepared by dialyzing CD samples at 70 mM against a solution KCl 5 mM, Tris 5 
mM and MgCl2 1 mM. CD spectra of all G-quadruplexes and CD melting curves were 
registered on a Jasco 715 CD spectrophotometer. For the CD spectra, the wavelength was 
varied from 220 to 320 nm at 100 nm min-1 scan rate, and the spectra recorded with a 
response of 4 s, at 1.0 nm bandwidth and normalized by subtraction of the background 
scan with buffer. The temperature was kept constant at 20°C with a thermoelectrically-
controlled cell holder (Jasco PTC-348). CD melting curves were registered as a function 
of temperature from 20°C to 70°C for all G-quadruplexes at their maximum Cotton effect 
wavelengths. The CD data were recorded in a 0.1 cm pathlength cuvette with a scan rate 
of 0.5°C/min. 
 
9.4. SDS-PAGE and Western blotting 
All recombinant proteins were loaded onto a 10% (w/v) sodium dodecyl sulphate-
polyacrylamide (SDS-PAGE; acr:bis= 37.5:1) electrophoresis gel, which was 
subsequently stained using Coomassie Brilliant Blue stain (ThermoFisher). Each band, 
corresponding to the protein of interest, was quantified and normalized with BSA (bovine 
serum albumin) standardization curve. The image was finally developed by using NIR 
Fluorescence technology with an Odissey CLx scanner (LI-COR GmbH). Bands were 
quantified and analyzed using the ImageStudio software (LI-COR GmbH).  
Cell extracts samples were loaded onto a 12 (w/v) % SDS-PAGE electrophoresis gel. 
Proteins were then transferred onto nitrocellulose membranes (Schleicher & Schuell). 
Monoclonal α-Ape1 was from Novus Biologicals (1:5,000 dilution). Membranes were 
incubated with secondary antibodies labeled with IRDye (1:10,000 dilution) in 5% milk, 
PBS and Tween 0.1% and finally developed by using NIR Fluorescence technology with 
an Odissey CLx scanner (LI-COR GmbH). Bands were quantified and analyzed using the 




9.5. Electrophoretic mobility shift assay (EMSA) 
EMSA assays were performed incubating 20 pmol of Ape1 protein (2 µM) with 250 fmol 
of the substrate (0.025 µM) for 1 hour at RT in 25 mM Tris, 100 mM KCl, 2 mM DTT, 
10% glycerol, pH 7.5. Alternatively, EMSA assays were done with 3.5 pmol of NPM1 or 
with 7 pmol of Ape1WT or Ape1N∆33, co-incubated for 1 h at RT with increasing 
concentrations of NPM1 (varying between 3.5 and 17.5 pmol); 350 fmol of Nat substrate 
were added and left to incubate for 1 h at RT during the binding reactions. The mixtures 
were loaded on a native gel 6% polyacrylamide (acr: bis= 37.5: 1) then run in the cold 
apparatus (at 4°C) at 130 V for 4 hours using 0.5x TBE as buffer. Gels were scanned and 
band intensities were quantified using the Image Studio software (Odyssey CLx, LI-COR 
GmbH). 
 
9.6. UV-crosslinking experiments 
UV-crosslinking analysis were performed co-incubating 20 pmol of recombinant purified 
protein (Ape1WT, of Ape1NΔ33 or Ape1K4pleA) for 1.5 h at 4°C with 250 fmol of S4 or S8 
ODN. Alternatively, UV-crosslinking analysis were performed with Immunoprecipitated 
(IP) samples obtained from transfected U2OS cells employing 2 pmol of Ape1, co-
incubated for 40 min at RT with 250 fmol of the G4-structured ODN in AP buffer 
containing 5 mM KCl and 1 mM MgCl2. 
The mixtures were UV-crosslinked using a Vilber Lourmat UV-crosslinker BLX-254 at 
0.2 J/cm2 and run onto SDS-PAGE 10% acrylamide. 
 
9.7. Cell cultures, transfection and Co-
immunoprecipitation 
U2OS cells were grown in DMEM (EuroClone) medium supplemented with 10% fetal 
bovine serum (FBS, EuroClone), L-glutamine (2mM), penicillin (100 U/ml) and 
streptomycin (100 mg/ml) and cultured in a humidified incubator at 5% CO2 at 37°C. 
HeLa stable clones were grown as indicated in (Vascotto et al. 2009) and harvested 10 
days after the addition of doxycycline in the medium (Vascotto et al. 2009). OCI/AML2 
and OCI/AML3 cells were grown in MEM-α (EuroClone) supplemented with 20% heat-
inactivated FBS, L-glutamine (2mM), penicillin (100 U/ml) and streptomycin (100 
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mg/ml) and cultured in a humidified incubator at 5% CO2 at 37°C. CH12F3 cells were 
grown in RPMI 1640 (EuroClone) supplemented with non-essential amino acids, Na 
pyruvate, 10% FBS, Hepes (25 mM), β-mercaptoethanol (50 µM), L-glutamine (2mM), 
penicillin (100 U/ml) and streptomycin (100 mg/ml) and cultured in a humidified 
incubator at 5% CO2 at 37°C (Masani, Han, and Yu 2013). 
Co-immunoprecipitation studies were carried out with whole cell extracts from U2OS 
cells transfected with FLAG-tagged Ape1 mutants (Ape1WT-Flag, Ape1NΔ33-Flag, 
Ape1K4pleA-Flag, Ape1K4pleQ-Flag and Ape1K4pleR-Flag). The cells were transiently 
transfected using 12 µg of DNA and 36 µL of Lipofectamine 3000 (Invitrogen). Cells 
were harvested 24 hours upon transfection, washed twice with PBS and re-suspended in 
lysis buffer (50 mM Tris HCl pH 7.4, 150 mM NaCl, 1 mM EDTA and 1 % Triton X-
100) containing proteases inhibitor cocktail. After incubation for 20 minutes at 4°C under 
rotation, cell lysates were clarified by centrifugation at 12,000 × g for 10 minutes at 4°C 
and co-immunoprecipitation was performed with anti-FLAG M2 affinity gel (Sigma-
Aldrich) at 4°C with gentle rocking for 3 hours. After washing three times with Tris-
buffered saline (TBS), immunoprecipitates (IP) were then eluted by incubation with 0.15 
mg/ml FLAG peptide in TBS and analyzed as indicated. Samples were then loaded onto 
a 12 w/vol % SDS-PAGE electrophoresis gel. Proteins were then transferred to 
nitrocellulose membranes (Schleicher & Schuell). Monoclonal α-Ape1 was from Novus 
Biologicals (1:5,000 dilution). Membranes were incubated with secondary antibodies 
labeled with IRDye (1:10,000 dilution) in 5% milk, PBS and Tween 0.1%. All gel images 
were captured with an Odissey CLx scanner (LI-COR GmbH) and analyzed using the 
ImageStudio software (LI-COR GmbH). 
 
9.8. Chromatin immunoprecipitation and quantitative PCR 
Chromatin immunoprecipitation (ChIP) was performed using the Diagenode High cell 
number ChIP kit, according to the manual. After colturing HeLa cells stably carrying 
p3XFLAG-CMV vectors in doxycycline 1 µg/ml, as previously described (Vascotto et 
al. 2009), the cells were crosslinked with 1% formaldehyde for 10 minutes at RT, and 
sonicated with the Diagenode bioruptor. Samples were immunoprecipitated overnight 
with anti-FLAG (Sigma-Aldrich). Telomeric DNA sequences were amplified by PCR 
using SensiFAST SYBR No-ROX Kit (Bioline). 
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The primer sequences were telomere forward primer (Tel 1) 5’-GGTTTTTGAGGG- 
TGAGGGTGAGGGTGAGGGTGAGGGT-3’; telomere reverse primer (Tel 2), 5’-
TCCCGACTATCCCTATCCCTATCCCTATCCCTATCCCTA-3’; 36B4 forward 
primer, 5’-CAGCAAGTGGGAAGGTGTAATCC-3’; 36B4 reverse primer, 5’-
CCCATTCTATCATCAACGGGTACAA-3’ (Gil and Coetzer 2004; O’Callaghan et al. 
2008). Samples were run on a C1000 Thermal Cycler CFX96 Real-Time System 
(BIORAD). Each sample was analyzed in triplicate. 36B4, a single-copy gene that 
encodes the acidic ribosomal phosphoprotein P0, was used as a reference (O’Callaghan 
et al. 2008). PCR reactions (15 μL) were set up as follows: 1 μL of recovered ChIP DNA, 
2× SYBR Green master mix (Bioline), and the forward and reverse primers each at 100 
nM final concentration. The thermal cycling conditions were as follows: 10 min at 95 °C, 
followed by 40 cycles of 95 °C for 15 s and 60 °C for 1 min for both telomere and 36B4 
amplification. 
 
9.9. AP site incision assays 
Cleavage assays were performed either at high ionic strength (Tris 50 mM, KCl 50 mM, 
MgCl2 10 mM, BSA 1 µg/µl, triton X-100 0.05%) or at low ionic strength (Tris 5 mM, 
KCl 5 mM, MgCl2 1 mM, BSA 0.1 µg/µl, triton X-100 0.005%). A fixed amount of 
substrate (250 fmol) was incubated with an increasing amount of Ape1 proteins for 40 
minutes at 37°C. Alternatively, 10 pmol of Ape1WT were incubated for 1h at RT with 
increasing amounts of NPM1, varying between 5 and 200 pmol. Then the substrate S8 
was added for the reaction for 40 min at 37°C in a solution containing 50 mM KCl (final 
volume 10 µl). The reactions were in any case stopped by adding an equal volume of stop 
solution containing formamide (10 mM EDTA, 0.5 % bromophenol blue, 80 % 
formamide), followed by heating for 5 minutes at 95°C. The mixtures were loaded on a 
7 M urea 20% acrylamide gel and run in 0.5x TBE at 130 V for 50 minutes. The intensity 
of the obtained bands was determined using a fluorescence scanner (Odyssey CLx, LI-
COR GmbH) and the quantification was obtained calculating the ratio between the 
product intensity over the sum between the intensities of the product and the substrate. 
The signals of the non-incised substrate (S) and the incision product (P) bands were 




9.10. Surface Plasmon Resonance (SPR) experiments 
Real-time binding assays were performed at 25 °C on a Biacore 3000 Surface Plasmon 
Resonance (SPR) instrument (GE Healthcare). For immobilization, 5'-biotinylated Nat 
and Poly dT ODN were injected at a concentration of 20 µM on a SA Biacore sensor chip 
until the desired level of immobilization was achieved (averaged value of 700 RU) in an 
injection time of 7 min. Binding assays were carried out by injecting 90 µL of analyte, at 
20 µL x min-1. Experiments were carried out at pH 7.4 using HBS (10 mM Hepes, 150 
mM NaCl, 3 mM EDTA, pH 7.4). The association phase (kon) was followed for 270 s, 
whereas the dissociation phase (koff) was followed for 300 s. The reference chip 
sensorgrams were properly subtracted to sample sensorgrams. After each cycle, the 
sensor chip surface was regenerated with a 1.0 M NaCl solution for 30 s followed by 
multiple buffer injections to yield a stable baseline for the following cycles. Analyte 
concentrations were in the range 50-1000 nM, for all proteins. Experiments were carried 
out in duplicates. Kinetic parameters were estimated assuming a 1:1 binding model and 
using version 4.1 Evaluation Software (GE Healthcare). 
 
9.11. Telomeric length assay 
Telomere length analysis was performed employing TeloTAGGG Telomere Length 
Assay Kit (Roche). Genomic DNA was isolated form OCI/AML2, OCI/AML3, CH12F3 
cells using the Blood & Cell Culture DNA Midi kit (Qiagen). OCI/AML2 were treated 
with #3 500 nM (G. Rai et al. 2010), or with DMSO as control, for 7 days. After digestion 
with Hinf I and Rsa I, DNA was separated on 0.8% agarose gel. Following denaturation, 
the DNA was transferred to a HybondN+ membrane (Boehringer Mannheim) and 
hybridized with a digoxigenin-labeled telomeric probe included in the kit. Non-
radioactive telomeric signal intensity was scanned with high resolution 
chemiluminescence settings using a Molecular Imager Chemidoc XRS scanner (Bio Rad) 
with Image Lab™ Software (Bio Rad). The length of the fragments was quantified using 
the TeloTool software version 1.3 (Matlab) (Göhring et al. 2014). 
9.12. GST pull-down assay 
300 pmol of NPM1 were added, together with 100 pmol of GST or Ape1-GST, to 15 µl 
of glutathione-sepharose 4B beads (GE healthcare). Binding was performed in AP buffer 
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1x at 4°C for 2h, under rotation. The beads were washed three times with PBS 1x 
supplemented with 0.1% w/v Igepal (CA-630 Sigma). Elution was performed with GSH 
10 mM and the obtained samples were analyzed through western blot. Anti-GST (Sigma 
H9658) and anti-NPM1 (Invitrogen 32-5200) antibodies were employed. 
 
9.13. Statistical analysis 
Statistical analyses were performed by using the Student’s t test. P <0.05 was considered 
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